JPH11508244A - バソプレッシン拮抗物質としてのベンズアミド誘導体およびその用途 - Google Patents
バソプレッシン拮抗物質としてのベンズアミド誘導体およびその用途Info
- Publication number
- JPH11508244A JPH11508244A JP9502896A JP50289697A JPH11508244A JP H11508244 A JPH11508244 A JP H11508244A JP 9502896 A JP9502896 A JP 9502896A JP 50289697 A JP50289697 A JP 50289697A JP H11508244 A JPH11508244 A JP H11508244A
- Authority
- JP
- Japan
- Prior art keywords
- substituted
- amino
- acyl
- salt
- aryl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000003936 benzamides Chemical class 0.000 title abstract description 11
- 229940116211 Vasopressin antagonist Drugs 0.000 title description 2
- 239000003038 vasopressin antagonist Substances 0.000 title description 2
- 125000003545 alkoxy group Chemical group 0.000 claims abstract description 142
- 125000000217 alkyl group Chemical group 0.000 claims abstract description 113
- 229910052739 hydrogen Inorganic materials 0.000 claims abstract description 93
- 125000003118 aryl group Chemical group 0.000 claims abstract description 77
- 239000001257 hydrogen Substances 0.000 claims abstract description 27
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims abstract description 17
- 229960003726 vasopressin Drugs 0.000 claims abstract description 13
- GXBMIBRIOWHPDT-UHFFFAOYSA-N Vasopressin Natural products N1C(=O)C(CC=2C=C(O)C=CC=2)NC(=O)C(N)CSSCC(C(=O)N2C(CCC2)C(=O)NC(CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(CCC(N)=O)NC(=O)C1CC1=CC=CC=C1 GXBMIBRIOWHPDT-UHFFFAOYSA-N 0.000 claims abstract description 12
- 108010004977 Vasopressins Proteins 0.000 claims abstract description 12
- 102000002852 Vasopressins Human genes 0.000 claims abstract description 12
- KBZOIRJILGZLEJ-LGYYRGKSSA-N argipressin Chemical compound C([C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CSSC[C@@H](C(N[C@@H](CC=2C=CC(O)=CC=2)C(=O)N1)=O)N)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)C1=CC=CC=C1 KBZOIRJILGZLEJ-LGYYRGKSSA-N 0.000 claims abstract description 11
- -1 hydroxyimino Chemical group 0.000 claims description 657
- 150000001875 compounds Chemical class 0.000 claims description 331
- 150000003839 salts Chemical class 0.000 claims description 230
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 141
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 132
- 125000003282 alkyl amino group Chemical group 0.000 claims description 126
- 238000000034 method Methods 0.000 claims description 123
- 125000002252 acyl group Chemical group 0.000 claims description 113
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 claims description 87
- 125000004442 acylamino group Chemical group 0.000 claims description 62
- 125000000623 heterocyclic group Chemical group 0.000 claims description 53
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 53
- 125000004414 alkyl thio group Chemical group 0.000 claims description 51
- 238000004519 manufacturing process Methods 0.000 claims description 49
- 125000004423 acyloxy group Chemical group 0.000 claims description 42
- 239000002253 acid Substances 0.000 claims description 41
- 125000005115 alkyl carbamoyl group Chemical group 0.000 claims description 41
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 claims description 38
- 125000000676 alkoxyimino group Chemical group 0.000 claims description 37
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 claims description 34
- 150000002367 halogens Chemical class 0.000 claims description 30
- 229910052736 halogen Inorganic materials 0.000 claims description 29
- 125000004390 alkyl sulfonyl group Chemical group 0.000 claims description 28
- 125000003107 substituted aryl group Chemical group 0.000 claims description 23
- 125000003342 alkenyl group Chemical group 0.000 claims description 22
- 239000003638 chemical reducing agent Substances 0.000 claims description 22
- 125000004076 pyridyl group Chemical class 0.000 claims description 22
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 claims description 19
- 125000000304 alkynyl group Chemical group 0.000 claims description 19
- 125000004644 alkyl sulfinyl group Chemical group 0.000 claims description 16
- 150000001412 amines Chemical class 0.000 claims description 15
- 230000014509 gene expression Effects 0.000 claims description 14
- 241000257303 Hymenoptera Species 0.000 claims description 13
- 125000003302 alkenyloxy group Chemical group 0.000 claims description 13
- 239000002585 base Substances 0.000 claims description 13
- 125000005278 alkyl sulfonyloxy group Chemical group 0.000 claims description 12
- 125000002795 guanidino group Chemical group C(N)(=N)N* 0.000 claims description 12
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims description 11
- 229910052783 alkali metal Inorganic materials 0.000 claims description 10
- 125000002947 alkylene group Chemical group 0.000 claims description 10
- 125000003277 amino group Chemical group 0.000 claims description 10
- 125000004093 cyano group Chemical group *C#N 0.000 claims description 10
- 238000003379 elimination reaction Methods 0.000 claims description 10
- 229910021529 ammonia Inorganic materials 0.000 claims description 9
- 125000005279 aryl sulfonyloxy group Chemical group 0.000 claims description 9
- 150000002431 hydrogen Chemical class 0.000 claims description 9
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims description 9
- 125000004453 alkoxycarbonyl group Chemical group 0.000 claims description 8
- 239000003795 chemical substances by application Substances 0.000 claims description 8
- 150000001340 alkali metals Chemical class 0.000 claims description 7
- 125000004391 aryl sulfonyl group Chemical group 0.000 claims description 7
- 125000003106 haloaryl group Chemical group 0.000 claims description 7
- 125000005236 alkanoylamino group Chemical group 0.000 claims description 6
- 208000026106 cerebrovascular disease Diseases 0.000 claims description 6
- 238000007257 deesterification reaction Methods 0.000 claims description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 6
- 125000003944 tolyl group Chemical group 0.000 claims description 6
- 208000027530 Meniere disease Diseases 0.000 claims description 5
- 125000004450 alkenylene group Chemical group 0.000 claims description 5
- 125000004471 alkyl aminosulfonyl group Chemical group 0.000 claims description 5
- 125000002485 formyl group Chemical group [H]C(*)=O 0.000 claims description 5
- 125000001424 substituent group Chemical group 0.000 claims description 5
- 208000011580 syndromic disease Diseases 0.000 claims description 5
- 206010003445 Ascites Diseases 0.000 claims description 4
- 206010016654 Fibrosis Diseases 0.000 claims description 4
- 206010019280 Heart failures Diseases 0.000 claims description 4
- 206010020772 Hypertension Diseases 0.000 claims description 4
- 206010021036 Hyponatraemia Diseases 0.000 claims description 4
- 241001465754 Metazoa Species 0.000 claims description 4
- 206010030113 Oedema Diseases 0.000 claims description 4
- 208000001647 Renal Insufficiency Diseases 0.000 claims description 4
- 230000007882 cirrhosis Effects 0.000 claims description 4
- 208000019425 cirrhosis of liver Diseases 0.000 claims description 4
- 238000006264 debenzylation reaction Methods 0.000 claims description 4
- 208000035475 disorder Diseases 0.000 claims description 4
- 150000002440 hydroxy compounds Chemical class 0.000 claims description 4
- 201000006370 kidney failure Diseases 0.000 claims description 4
- 201000003152 motion sickness Diseases 0.000 claims description 4
- 229910052760 oxygen Inorganic materials 0.000 claims description 4
- XKJCHHZQLQNZHY-UHFFFAOYSA-N phthalimide Chemical compound C1=CC=C2C(=O)NC(=O)C2=C1 XKJCHHZQLQNZHY-UHFFFAOYSA-N 0.000 claims description 4
- 230000028327 secretion Effects 0.000 claims description 4
- 125000000020 sulfo group Chemical group O=S(=O)([*])O[H] 0.000 claims description 4
- 239000005749 Copper compound Substances 0.000 claims description 3
- 208000019025 Hypokalemia Diseases 0.000 claims description 3
- 239000004480 active ingredient Substances 0.000 claims description 3
- 150000001880 copper compounds Chemical class 0.000 claims description 3
- 206010012601 diabetes mellitus Diseases 0.000 claims description 3
- 150000008049 diazo compounds Chemical class 0.000 claims description 3
- 239000003814 drug Substances 0.000 claims description 3
- MLACQEBQGUBHKX-UHFFFAOYSA-N n,n-dimethylpiperidin-1-amine Chemical compound CN(C)N1CCCCC1 MLACQEBQGUBHKX-UHFFFAOYSA-N 0.000 claims description 3
- 150000002941 palladium compounds Chemical class 0.000 claims description 3
- 239000008194 pharmaceutical composition Substances 0.000 claims description 3
- 208000024896 potassium deficiency disease Diseases 0.000 claims description 3
- 125000006239 protecting group Chemical group 0.000 claims description 3
- 238000005947 deacylation reaction Methods 0.000 claims description 2
- 231100000252 nontoxic Toxicity 0.000 claims description 2
- 230000003000 nontoxic effect Effects 0.000 claims description 2
- 239000000546 pharmaceutical excipient Substances 0.000 claims description 2
- 125000005543 phthalimide group Chemical group 0.000 claims description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 34
- 235000014676 Phragmites communis Nutrition 0.000 claims 1
- 230000002159 abnormal effect Effects 0.000 claims 1
- 125000001951 carbamoylamino group Chemical group C(N)(=O)N* 0.000 claims 1
- 206010013990 dysuria Diseases 0.000 claims 1
- 125000001072 heteroaryl group Chemical group 0.000 claims 1
- 229940037201 oris Drugs 0.000 claims 1
- 230000008485 antagonism Effects 0.000 abstract description 3
- 229910052717 sulfur Inorganic materials 0.000 abstract description 2
- 238000006243 chemical reaction Methods 0.000 description 218
- 239000000243 solution Substances 0.000 description 163
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 160
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 description 146
- 239000002904 solvent Substances 0.000 description 122
- KXDAEFPNCMNJSK-UHFFFAOYSA-N Benzamide Chemical compound NC(=O)C1=CC=CC=C1 KXDAEFPNCMNJSK-UHFFFAOYSA-N 0.000 description 120
- 239000000203 mixture Substances 0.000 description 118
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 112
- 125000004195 4-methylpiperazin-1-yl group Chemical group [H]C([H])([H])N1C([H])([H])C([H])([H])N(*)C([H])([H])C1([H])[H] 0.000 description 107
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 105
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 102
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 100
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 82
- GTKIGDZXPDCIKR-UHFFFAOYSA-N 2-phenylbenzamide Chemical compound NC(=O)C1=CC=CC=C1C1=CC=CC=C1 GTKIGDZXPDCIKR-UHFFFAOYSA-N 0.000 description 74
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 63
- UERSZVOVPLBEHC-UHFFFAOYSA-N n-methyl-2-phenylbenzamide Chemical compound CNC(=O)C1=CC=CC=C1C1=CC=CC=C1 UERSZVOVPLBEHC-UHFFFAOYSA-N 0.000 description 62
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 61
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 54
- 239000012267 brine Substances 0.000 description 53
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 53
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical class [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 43
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 41
- 235000019341 magnesium sulphate Nutrition 0.000 description 41
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 39
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 36
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 35
- 125000004356 hydroxy functional group Chemical group O* 0.000 description 32
- 239000012044 organic layer Substances 0.000 description 30
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 30
- 125000005544 phthalimido group Chemical group 0.000 description 28
- 238000010898 silica gel chromatography Methods 0.000 description 28
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 27
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 27
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 27
- 238000010438 heat treatment Methods 0.000 description 26
- 125000006633 tert-butoxycarbonylamino group Chemical group 0.000 description 25
- 125000003816 2-hydroxybenzoyl group Chemical group OC1=C(C(=O)*)C=CC=C1 0.000 description 24
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 23
- 238000001816 cooling Methods 0.000 description 23
- 229920006395 saturated elastomer Polymers 0.000 description 22
- 239000003054 catalyst Substances 0.000 description 21
- 239000012043 crude product Substances 0.000 description 21
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 21
- 239000011541 reaction mixture Substances 0.000 description 21
- 238000006722 reduction reaction Methods 0.000 description 21
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 20
- 230000002411 adverse Effects 0.000 description 20
- 229910004298 SiO 2 Inorganic materials 0.000 description 19
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 19
- 235000017557 sodium bicarbonate Nutrition 0.000 description 19
- 125000005931 tert-butyloxycarbonyl group Chemical group [H]C([H])([H])C(OC(*)=O)(C([H])([H])[H])C([H])([H])[H] 0.000 description 19
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 16
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 15
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 15
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 15
- 239000003921 oil Substances 0.000 description 15
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 14
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 14
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 14
- 239000007864 aqueous solution Substances 0.000 description 14
- 235000011054 acetic acid Nutrition 0.000 description 13
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 13
- 238000010531 catalytic reduction reaction Methods 0.000 description 13
- 238000001704 evaporation Methods 0.000 description 13
- 230000008020 evaporation Effects 0.000 description 13
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 12
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 12
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 12
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 12
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 12
- CTSLXHKWHWQRSH-UHFFFAOYSA-N oxalyl chloride Chemical compound ClC(=O)C(Cl)=O CTSLXHKWHWQRSH-UHFFFAOYSA-N 0.000 description 12
- 229910052697 platinum Inorganic materials 0.000 description 12
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 12
- OAEBNNHZRMTPRC-UHFFFAOYSA-N 2-phenylbenzamide;dihydrochloride Chemical compound Cl.Cl.NC(=O)C1=CC=CC=C1C1=CC=CC=C1 OAEBNNHZRMTPRC-UHFFFAOYSA-N 0.000 description 11
- 229910052757 nitrogen Inorganic materials 0.000 description 11
- 239000000741 silica gel Substances 0.000 description 11
- 229910002027 silica gel Inorganic materials 0.000 description 11
- UDSRUCAJZSIRHZ-UHFFFAOYSA-N benzamide dihydrochloride Chemical compound Cl.Cl.NC(=O)C1=CC=CC=C1.NC(=O)C1=CC=CC=C1 UDSRUCAJZSIRHZ-UHFFFAOYSA-N 0.000 description 10
- 238000001914 filtration Methods 0.000 description 10
- 239000007788 liquid Substances 0.000 description 10
- 125000004433 nitrogen atom Chemical group N* 0.000 description 10
- 229910052763 palladium Inorganic materials 0.000 description 10
- 239000011734 sodium Substances 0.000 description 10
- RIOQSEWOXXDEQQ-UHFFFAOYSA-N triphenylphosphine Chemical compound C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 RIOQSEWOXXDEQQ-UHFFFAOYSA-N 0.000 description 10
- 150000003973 alkyl amines Chemical class 0.000 description 9
- 239000000872 buffer Substances 0.000 description 9
- 229910017052 cobalt Inorganic materials 0.000 description 9
- 239000010941 cobalt Substances 0.000 description 9
- 229910052802 copper Inorganic materials 0.000 description 9
- 239000010949 copper Substances 0.000 description 9
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 9
- 239000000725 suspension Substances 0.000 description 9
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 8
- ATUOYWHBWRKTHZ-UHFFFAOYSA-N Propane Chemical compound CCC ATUOYWHBWRKTHZ-UHFFFAOYSA-N 0.000 description 8
- 150000008065 acid anhydrides Chemical class 0.000 description 8
- 150000007513 acids Chemical class 0.000 description 8
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 8
- 125000002911 monocyclic heterocycle group Chemical group 0.000 description 8
- 150000007524 organic acids Chemical class 0.000 description 8
- 239000012279 sodium borohydride Substances 0.000 description 8
- 229910000033 sodium borohydride Inorganic materials 0.000 description 8
- 239000007858 starting material Substances 0.000 description 8
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 8
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 7
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 7
- 125000000051 benzyloxy group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])O* 0.000 description 7
- 125000001589 carboacyl group Chemical group 0.000 description 7
- 230000007062 hydrolysis Effects 0.000 description 7
- 238000006460 hydrolysis reaction Methods 0.000 description 7
- 125000004482 piperidin-4-yl group Chemical group N1CCC(CC1)* 0.000 description 7
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 7
- 239000007787 solid Substances 0.000 description 7
- 125000002379 2-iodobenzoyl group Chemical group IC1=C(C(=O)*)C=CC=C1 0.000 description 6
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 6
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 6
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 6
- BAVYZALUXZFZLV-UHFFFAOYSA-N Methylamine Chemical compound NC BAVYZALUXZFZLV-UHFFFAOYSA-N 0.000 description 6
- SJRJJKPEHAURKC-UHFFFAOYSA-N N-Methylmorpholine Chemical compound CN1CCOCC1 SJRJJKPEHAURKC-UHFFFAOYSA-N 0.000 description 6
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 6
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 6
- 125000003668 acetyloxy group Chemical group [H]C([H])([H])C(=O)O[*] 0.000 description 6
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 description 6
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 6
- 235000019253 formic acid Nutrition 0.000 description 6
- 230000002401 inhibitory effect Effects 0.000 description 6
- 229910052742 iron Inorganic materials 0.000 description 6
- 229910052751 metal Inorganic materials 0.000 description 6
- 239000002184 metal Substances 0.000 description 6
- 150000007522 mineralic acids Chemical class 0.000 description 6
- 125000000740 n-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 6
- 125000004430 oxygen atom Chemical group O* 0.000 description 6
- XHXFXVLFKHQFAL-UHFFFAOYSA-N phosphoryl trichloride Chemical compound ClP(Cl)(Cl)=O XHXFXVLFKHQFAL-UHFFFAOYSA-N 0.000 description 6
- 229910000027 potassium carbonate Inorganic materials 0.000 description 6
- 235000019260 propionic acid Nutrition 0.000 description 6
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 6
- 229910052708 sodium Inorganic materials 0.000 description 6
- 239000012312 sodium hydride Substances 0.000 description 6
- 229910000104 sodium hydride Inorganic materials 0.000 description 6
- FVAUCKIRQBBSSJ-UHFFFAOYSA-M sodium iodide Chemical compound [Na+].[I-] FVAUCKIRQBBSSJ-UHFFFAOYSA-M 0.000 description 6
- 125000000472 sulfonyl group Chemical group *S(*)(=O)=O 0.000 description 6
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 6
- GETQZCLCWQTVFV-UHFFFAOYSA-N trimethylamine Chemical compound CN(C)C GETQZCLCWQTVFV-UHFFFAOYSA-N 0.000 description 6
- PVOAHINGSUIXLS-UHFFFAOYSA-N 1-Methylpiperazine Chemical compound CN1CCNCC1 PVOAHINGSUIXLS-UHFFFAOYSA-N 0.000 description 5
- TVVLYOPQYYREOW-UHFFFAOYSA-N 2-phenylbenzamide;hydrochloride Chemical compound Cl.NC(=O)C1=CC=CC=C1C1=CC=CC=C1 TVVLYOPQYYREOW-UHFFFAOYSA-N 0.000 description 5
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 5
- QUSNBJAOOMFDIB-UHFFFAOYSA-N Ethylamine Chemical compound CCN QUSNBJAOOMFDIB-UHFFFAOYSA-N 0.000 description 5
- RXQOAZKREPPDEV-UHFFFAOYSA-N N-methyl-2-phenylbenzamide dihydrochloride Chemical compound Cl.Cl.C1(=CC=CC=C1)C1=C(C(=O)NC)C=CC=C1 RXQOAZKREPPDEV-UHFFFAOYSA-N 0.000 description 5
- GLUUGHFHXGJENI-UHFFFAOYSA-N Piperazine Chemical compound C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 description 5
- 125000006630 butoxycarbonylamino group Chemical group 0.000 description 5
- 125000004432 carbon atom Chemical group C* 0.000 description 5
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 description 5
- 238000001035 drying Methods 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 150000002148 esters Chemical class 0.000 description 5
- 150000002739 metals Chemical class 0.000 description 5
- 239000007800 oxidant agent Substances 0.000 description 5
- 238000002360 preparation method Methods 0.000 description 5
- 229910052938 sodium sulfate Inorganic materials 0.000 description 5
- 235000011152 sodium sulphate Nutrition 0.000 description 5
- 238000003756 stirring Methods 0.000 description 5
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 5
- FPQQSJJWHUJYPU-UHFFFAOYSA-N 3-(dimethylamino)propyliminomethylidene-ethylazanium;chloride Chemical compound Cl.CCN=C=NCCCN(C)C FPQQSJJWHUJYPU-UHFFFAOYSA-N 0.000 description 4
- VHYFNPMBLIVWCW-UHFFFAOYSA-N 4-Dimethylaminopyridine Chemical compound CN(C)C1=CC=NC=C1 VHYFNPMBLIVWCW-UHFFFAOYSA-N 0.000 description 4
- QOSSAOTZNIDXMA-UHFFFAOYSA-N Dicylcohexylcarbodiimide Chemical compound C1CCCCC1N=C=NC1CCCCC1 QOSSAOTZNIDXMA-UHFFFAOYSA-N 0.000 description 4
- ROSDSFDQCJNGOL-UHFFFAOYSA-N Dimethylamine Chemical compound CNC ROSDSFDQCJNGOL-UHFFFAOYSA-N 0.000 description 4
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 4
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 4
- NBBJYMSMWIIQGU-UHFFFAOYSA-N Propionic aldehyde Chemical compound CCC=O NBBJYMSMWIIQGU-UHFFFAOYSA-N 0.000 description 4
- ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 description 4
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 4
- 150000001408 amides Chemical class 0.000 description 4
- 238000007796 conventional method Methods 0.000 description 4
- 239000000706 filtrate Substances 0.000 description 4
- 239000011521 glass Substances 0.000 description 4
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 4
- 229910000041 hydrogen chloride Inorganic materials 0.000 description 4
- 239000010410 layer Substances 0.000 description 4
- 229910001629 magnesium chloride Inorganic materials 0.000 description 4
- 150000002736 metal compounds Chemical class 0.000 description 4
- 229910052759 nickel Inorganic materials 0.000 description 4
- 235000005985 organic acids Nutrition 0.000 description 4
- 239000003960 organic solvent Substances 0.000 description 4
- 101150032584 oxy-4 gene Proteins 0.000 description 4
- 239000011591 potassium Substances 0.000 description 4
- 229910052700 potassium Inorganic materials 0.000 description 4
- 239000001294 propane Substances 0.000 description 4
- 238000010992 reflux Methods 0.000 description 4
- JQWHASGSAFIOCM-UHFFFAOYSA-M sodium periodate Chemical compound [Na+].[O-]I(=O)(=O)=O JQWHASGSAFIOCM-UHFFFAOYSA-M 0.000 description 4
- 125000004434 sulfur atom Chemical group 0.000 description 4
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 4
- 125000003831 tetrazolyl group Chemical group 0.000 description 4
- YNJBWRMUSHSURL-UHFFFAOYSA-N trichloroacetic acid Chemical compound OC(=O)C(Cl)(Cl)Cl YNJBWRMUSHSURL-UHFFFAOYSA-N 0.000 description 4
- ONDSBJMLAHVLMI-UHFFFAOYSA-N trimethylsilyldiazomethane Chemical compound C[Si](C)(C)[CH-][N+]#N ONDSBJMLAHVLMI-UHFFFAOYSA-N 0.000 description 4
- ASOKPJOREAFHNY-UHFFFAOYSA-N 1-Hydroxybenzotriazole Chemical compound C1=CC=C2N(O)N=NC2=C1 ASOKPJOREAFHNY-UHFFFAOYSA-N 0.000 description 3
- RMSGQZDGSZOJMU-UHFFFAOYSA-N 1-butyl-2-phenylbenzene Chemical group CCCCC1=CC=CC=C1C1=CC=CC=C1 RMSGQZDGSZOJMU-UHFFFAOYSA-N 0.000 description 3
- NGNBDVOYPDDBFK-UHFFFAOYSA-N 2-[2,4-di(pentan-2-yl)phenoxy]acetyl chloride Chemical compound CCCC(C)C1=CC=C(OCC(Cl)=O)C(C(C)CCC)=C1 NGNBDVOYPDDBFK-UHFFFAOYSA-N 0.000 description 3
- 125000003006 2-dimethylaminoethyl group Chemical group [H]C([H])([H])N(C([H])([H])[H])C([H])([H])C([H])([H])* 0.000 description 3
- RPESXCKKKMHKBY-UHFFFAOYSA-N 6-[2-[[3-methoxy-4-[[2-[3-[(2-methylpropan-2-yl)oxycarbonylamino]propoxy]benzoyl]amino]benzoyl]-methylamino]-5-methylphenoxy]hexanoic acid Chemical compound COC1=CC(C(=O)N(C)C=2C(=CC(C)=CC=2)OCCCCCC(O)=O)=CC=C1NC(=O)C1=CC=CC=C1OCCCNC(=O)OC(C)(C)C RPESXCKKKMHKBY-UHFFFAOYSA-N 0.000 description 3
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 3
- PAYRUJLWNCNPSJ-UHFFFAOYSA-N Aniline Chemical compound NC1=CC=CC=C1 PAYRUJLWNCNPSJ-UHFFFAOYSA-N 0.000 description 3
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical class OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 3
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 3
- 229910021555 Chromium Chloride Inorganic materials 0.000 description 3
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 3
- CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical compound Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 description 3
- 239000002841 Lewis acid Substances 0.000 description 3
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 3
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 3
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 3
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 3
- RWRDLPDLKQPQOW-UHFFFAOYSA-N Pyrrolidine Chemical compound C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 description 3
- 239000007868 Raney catalyst Substances 0.000 description 3
- 229910000564 Raney nickel Inorganic materials 0.000 description 3
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 3
- 150000001342 alkaline earth metals Chemical class 0.000 description 3
- 125000000043 benzamido group Chemical group [H]N([*])C(=O)C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 3
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 3
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 3
- 239000011575 calcium Substances 0.000 description 3
- 229910052791 calcium Inorganic materials 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 239000000460 chlorine Substances 0.000 description 3
- QSWDMMVNRMROPK-UHFFFAOYSA-K chromium(3+) trichloride Chemical compound [Cl-].[Cl-].[Cl-].[Cr+3] QSWDMMVNRMROPK-UHFFFAOYSA-K 0.000 description 3
- WYYQVWLEPYFFLP-UHFFFAOYSA-K chromium(3+);triacetate Chemical compound [Cr+3].CC([O-])=O.CC([O-])=O.CC([O-])=O WYYQVWLEPYFFLP-UHFFFAOYSA-K 0.000 description 3
- 239000012230 colorless oil Substances 0.000 description 3
- 238000004440 column chromatography Methods 0.000 description 3
- 239000010779 crude oil Substances 0.000 description 3
- 125000000753 cycloalkyl group Chemical group 0.000 description 3
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 3
- UAOMVDZJSHZZME-UHFFFAOYSA-N diisopropylamine Chemical compound CC(C)NC(C)C UAOMVDZJSHZZME-UHFFFAOYSA-N 0.000 description 3
- 125000002147 dimethylamino group Chemical group [H]C([H])([H])N(*)C([H])([H])[H] 0.000 description 3
- 239000003480 eluent Substances 0.000 description 3
- 150000004820 halides Chemical class 0.000 description 3
- INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 description 3
- 150000007517 lewis acids Chemical class 0.000 description 3
- 239000012280 lithium aluminium hydride Substances 0.000 description 3
- 239000011777 magnesium Substances 0.000 description 3
- 229910052749 magnesium Inorganic materials 0.000 description 3
- QPJVMBTYPHYUOC-UHFFFAOYSA-N methyl benzoate Chemical compound COC(=O)C1=CC=CC=C1 QPJVMBTYPHYUOC-UHFFFAOYSA-N 0.000 description 3
- 229910000480 nickel oxide Inorganic materials 0.000 description 3
- 125000005968 oxazolinyl group Chemical group 0.000 description 3
- 125000002971 oxazolyl group Chemical group 0.000 description 3
- GNRSAWUEBMWBQH-UHFFFAOYSA-N oxonickel Chemical compound [Ni]=O GNRSAWUEBMWBQH-UHFFFAOYSA-N 0.000 description 3
- HBEQXAKJSGXAIQ-UHFFFAOYSA-N oxopalladium Chemical compound [Pd]=O HBEQXAKJSGXAIQ-UHFFFAOYSA-N 0.000 description 3
- MUMZUERVLWJKNR-UHFFFAOYSA-N oxoplatinum Chemical compound [Pt]=O MUMZUERVLWJKNR-UHFFFAOYSA-N 0.000 description 3
- 229910003445 palladium oxide Inorganic materials 0.000 description 3
- NXJCBFBQEVOTOW-UHFFFAOYSA-L palladium(2+);dihydroxide Chemical compound O[Pd]O NXJCBFBQEVOTOW-UHFFFAOYSA-L 0.000 description 3
- 239000008188 pellet Substances 0.000 description 3
- 210000004623 platelet-rich plasma Anatomy 0.000 description 3
- 229910003446 platinum oxide Inorganic materials 0.000 description 3
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 3
- 125000002572 propoxy group Chemical group [*]OC([H])([H])C(C([H])([H])[H])([H])[H] 0.000 description 3
- 125000000714 pyrimidinyl group Chemical group 0.000 description 3
- 125000000168 pyrrolyl group Chemical group 0.000 description 3
- 102000005962 receptors Human genes 0.000 description 3
- 108020003175 receptors Proteins 0.000 description 3
- 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 3
- BEOOHQFXGBMRKU-UHFFFAOYSA-N sodium cyanoborohydride Chemical compound [Na+].[B-]C#N BEOOHQFXGBMRKU-UHFFFAOYSA-N 0.000 description 3
- 125000000335 thiazolyl group Chemical group 0.000 description 3
- 125000001544 thienyl group Chemical group 0.000 description 3
- 229910052718 tin Inorganic materials 0.000 description 3
- 239000011135 tin Substances 0.000 description 3
- 229920002554 vinyl polymer Polymers 0.000 description 3
- 239000008096 xylene Substances 0.000 description 3
- 229910052725 zinc Inorganic materials 0.000 description 3
- 239000011701 zinc Substances 0.000 description 3
- WSLDOOZREJYCGB-UHFFFAOYSA-N 1,2-Dichloroethane Chemical compound ClCCCl WSLDOOZREJYCGB-UHFFFAOYSA-N 0.000 description 2
- SGUVLZREKBPKCE-UHFFFAOYSA-N 1,5-diazabicyclo[4.3.0]-non-5-ene Chemical compound C1CCN=C2CCCN21 SGUVLZREKBPKCE-UHFFFAOYSA-N 0.000 description 2
- 125000004066 1-hydroxyethyl group Chemical group [H]OC([H])([*])C([H])([H])[H] 0.000 description 2
- QSKBTBHUFYZGMF-UHFFFAOYSA-N 2-(3-acetamidopropoxy)-n-[4-[methyl-[2-[6-(4-methylpiperazin-1-yl)-6-oxohexoxy]phenyl]carbamoyl]phenyl]benzamide Chemical compound C=1C=CC=C(OCCCCCC(=O)N2CCN(C)CC2)C=1N(C)C(=O)C(C=C1)=CC=C1NC(=O)C1=CC=CC=C1OCCCNC(C)=O QSKBTBHUFYZGMF-UHFFFAOYSA-N 0.000 description 2
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 2
- GHEUWNLDSHCRHC-UHFFFAOYSA-N 2-[3-(dimethylamino)propoxy]-n-[4-[methyl-[2-[6-(4-methylpiperazin-1-yl)-6-oxohexoxy]phenyl]carbamoyl]phenyl]benzamide Chemical compound CN(C)CCCOC1=CC=CC=C1C(=O)NC1=CC=C(C(=O)N(C)C=2C(=CC=CC=2)OCCCCCC(=O)N2CCN(C)CC2)C=C1 GHEUWNLDSHCRHC-UHFFFAOYSA-N 0.000 description 2
- BJJLOLPFSPRCMX-UHFFFAOYSA-N 2-amino-3-methoxy-N-(2-methoxy-4-methylphenyl)-N-methylbenzamide Chemical compound NC1=C(C(=O)N(C)C2=C(C=C(C=C2)C)OC)C=CC=C1OC BJJLOLPFSPRCMX-UHFFFAOYSA-N 0.000 description 2
- WOUAROUIHXXCDO-UHFFFAOYSA-N 2-amino-3-methoxy-N-methyl-N-[4-methyl-2-[(4-pyridin-2-ylphenyl)methoxy]phenyl]benzamide Chemical compound NC1=C(C(=O)N(C)C2=C(C=C(C=C2)C)OCC2=CC=C(C=C2)C2=NC=CC=C2)C=CC=C1OC WOUAROUIHXXCDO-UHFFFAOYSA-N 0.000 description 2
- FFUUHLRXWDPAAY-UHFFFAOYSA-N 2-amino-3-methoxy-N-methyl-N-[4-methyl-2-[[4-(1,3-oxazol-2-yl)phenyl]methoxy]phenyl]benzamide Chemical compound NC1=C(C(=O)N(C)C2=C(C=C(C=C2)C)OCC2=CC=C(C=C2)C=2OC=CN=2)C=CC=C1OC FFUUHLRXWDPAAY-UHFFFAOYSA-N 0.000 description 2
- QCIANVLFUJPDLC-UHFFFAOYSA-N 2-amino-N-[2-(4-aminobutoxy)-4-methylphenyl]-3-methoxy-N-methylbenzamide Chemical compound NC1=C(C(=O)N(C)C2=C(C=C(C=C2)C)OCCCCN)C=CC=C1OC QCIANVLFUJPDLC-UHFFFAOYSA-N 0.000 description 2
- BSYLKWSZBIICFY-UHFFFAOYSA-N 2-ethenyl-3-methoxybenzoic acid Chemical compound COC1=CC=CC(C(O)=O)=C1C=C BSYLKWSZBIICFY-UHFFFAOYSA-N 0.000 description 2
- GKNQAXXHMSSAKN-UHFFFAOYSA-N 2-hydroxy-n-[4-[methyl-[2-[6-(4-methylpiperazin-1-yl)-6-oxohexoxy]phenyl]carbamoyl]phenyl]benzamide Chemical compound C=1C=CC=C(OCCCCCC(=O)N2CCN(C)CC2)C=1N(C)C(=O)C(C=C1)=CC=C1NC(=O)C1=CC=CC=C1O GKNQAXXHMSSAKN-UHFFFAOYSA-N 0.000 description 2
- XXUNIGZDNWWYED-UHFFFAOYSA-N 2-methylbenzamide Chemical compound CC1=CC=CC=C1C(N)=O XXUNIGZDNWWYED-UHFFFAOYSA-N 0.000 description 2
- KDSNLYIMUZNERS-UHFFFAOYSA-N 2-methylpropanamine Chemical compound CC(C)CN KDSNLYIMUZNERS-UHFFFAOYSA-N 0.000 description 2
- BSKHPKMHTQYZBB-UHFFFAOYSA-N 2-methylpyridine Chemical compound CC1=CC=CC=N1 BSKHPKMHTQYZBB-UHFFFAOYSA-N 0.000 description 2
- NHQDETIJWKXCTC-UHFFFAOYSA-N 3-chloroperbenzoic acid Chemical compound OOC(=O)C1=CC=CC(Cl)=C1 NHQDETIJWKXCTC-UHFFFAOYSA-N 0.000 description 2
- ZGHZUKJSSSGZRX-UHFFFAOYSA-N 4-[[2-(3-aminopropoxy)benzoyl]amino]-3-methoxy-n-methyl-n-[4-methyl-2-[6-(4-methylpiperazin-1-yl)-6-oxohexoxy]phenyl]benzamide Chemical compound COC1=CC(C(=O)N(C)C=2C(=CC(C)=CC=2)OCCCCCC(=O)N2CCN(C)CC2)=CC=C1NC(=O)C1=CC=CC=C1OCCCN ZGHZUKJSSSGZRX-UHFFFAOYSA-N 0.000 description 2
- FSKDFQUAHCLAHJ-UHFFFAOYSA-N 4-amino-3-methoxy-n-methyl-n-[4-methyl-2-[6-(4-methylpiperazin-1-yl)-6-oxohexoxy]phenyl]benzamide Chemical compound C1=C(N)C(OC)=CC(C(=O)N(C)C=2C(=CC(C)=CC=2)OCCCCCC(=O)N2CCN(C)CC2)=C1 FSKDFQUAHCLAHJ-UHFFFAOYSA-N 0.000 description 2
- 125000004172 4-methoxyphenyl group Chemical group [H]C1=C([H])C(OC([H])([H])[H])=C([H])C([H])=C1* 0.000 description 2
- RJWLLQWLBMJCFD-UHFFFAOYSA-N 4-methylpiperazin-1-amine Chemical compound CN1CCN(N)CC1 RJWLLQWLBMJCFD-UHFFFAOYSA-N 0.000 description 2
- YYROPELSRYBVMQ-UHFFFAOYSA-N 4-toluenesulfonyl chloride Chemical compound CC1=CC=C(S(Cl)(=O)=O)C=C1 YYROPELSRYBVMQ-UHFFFAOYSA-N 0.000 description 2
- MHLFUUYLOCECRR-UHFFFAOYSA-N 6-[2-[(3-methoxy-4-nitrobenzoyl)-methylamino]-5-methylphenoxy]hexanoic acid Chemical compound C1=C([N+]([O-])=O)C(OC)=CC(C(=O)N(C)C=2C(=CC(C)=CC=2)OCCCCCC(O)=O)=C1 MHLFUUYLOCECRR-UHFFFAOYSA-N 0.000 description 2
- RTJDRQSHDLSXIC-UHFFFAOYSA-N 6-amino-N-[2-[6-[4-(dimethylamino)piperidin-1-yl]-6-oxohexoxy]-4-methylphenyl]-N-methylpyridine-3-carboxamide Chemical compound NC1=NC=C(C=C1)C(=O)N(C1=C(C=C(C=C1)C)OCCCCCC(=O)N1CCC(CC1)N(C)C)C RTJDRQSHDLSXIC-UHFFFAOYSA-N 0.000 description 2
- IKHGUXGNUITLKF-UHFFFAOYSA-N Acetaldehyde Chemical compound CC=O IKHGUXGNUITLKF-UHFFFAOYSA-N 0.000 description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 2
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 2
- 206010048962 Brain oedema Diseases 0.000 description 2
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 2
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 2
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Chemical compound CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 2
- FJLDSPVZFRLIAG-UHFFFAOYSA-N CNC(=O)C1=CC=CC=C1C2=CC=CC=C2.Cl Chemical compound CNC(=O)C1=CC=CC=C1C2=CC=CC=C2.Cl FJLDSPVZFRLIAG-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 2
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 2
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 2
- ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 2
- 241000282412 Homo Species 0.000 description 2
- OAKJQQAXSVQMHS-UHFFFAOYSA-N Hydrazine Chemical compound NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 2
- YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical compound C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 description 2
- JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 description 2
- CMLMVGFLLFSOTQ-UHFFFAOYSA-N NC1=C(C(=O)N(C)C2=C(C=C(C=C2)C)OCC2=CC=CC=C2)C=CC=C1OC Chemical compound NC1=C(C(=O)N(C)C2=C(C=C(C=C2)C)OCC2=CC=CC=C2)C=CC=C1OC CMLMVGFLLFSOTQ-UHFFFAOYSA-N 0.000 description 2
- HAJBLUACBSJKGZ-UHFFFAOYSA-N NC1=C(C(=O)N(C)C2=C(C=C(C=C2)C)OCCCCNC(=O)N2CCN(CC2)C)C=CC=C1OC Chemical compound NC1=C(C(=O)N(C)C2=C(C=C(C=C2)C)OCCCCNC(=O)N2CCN(CC2)C)C=CC=C1OC HAJBLUACBSJKGZ-UHFFFAOYSA-N 0.000 description 2
- 229910021586 Nickel(II) chloride Inorganic materials 0.000 description 2
- 101800000989 Oxytocin Proteins 0.000 description 2
- XNOPRXBHLZRZKH-UHFFFAOYSA-N Oxytocin Natural products N1C(=O)C(N)CSSCC(C(=O)N2C(CCC2)C(=O)NC(CC(C)C)C(=O)NCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(CCC(N)=O)NC(=O)C(C(C)CC)NC(=O)C1CC1=CC=C(O)C=C1 XNOPRXBHLZRZKH-UHFFFAOYSA-N 0.000 description 2
- 102100031951 Oxytocin-neurophysin 1 Human genes 0.000 description 2
- OFBQJSOFQDEBGM-UHFFFAOYSA-N Pentane Chemical compound CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 2
- KFSLWBXXFJQRDL-UHFFFAOYSA-N Peracetic acid Chemical compound CC(=O)OO KFSLWBXXFJQRDL-UHFFFAOYSA-N 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- PXIPVTKHYLBLMZ-UHFFFAOYSA-N Sodium azide Chemical compound [Na+].[N-]=[N+]=[N-] PXIPVTKHYLBLMZ-UHFFFAOYSA-N 0.000 description 2
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 2
- OKJPEAGHQZHRQV-UHFFFAOYSA-N Triiodomethane Natural products IC(I)I OKJPEAGHQZHRQV-UHFFFAOYSA-N 0.000 description 2
- 102000004136 Vasopressin Receptors Human genes 0.000 description 2
- 108090000643 Vasopressin Receptors Proteins 0.000 description 2
- BHIIGRBMZRSDRI-UHFFFAOYSA-N [chloro(phenoxy)phosphoryl]oxybenzene Chemical compound C=1C=CC=CC=1OP(=O)(Cl)OC1=CC=CC=C1 BHIIGRBMZRSDRI-UHFFFAOYSA-N 0.000 description 2
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 2
- AZDRQVAHHNSJOQ-UHFFFAOYSA-N alumane Chemical class [AlH3] AZDRQVAHHNSJOQ-UHFFFAOYSA-N 0.000 description 2
- RDOXTESZEPMUJZ-UHFFFAOYSA-N anisole Chemical compound COC1=CC=CC=C1 RDOXTESZEPMUJZ-UHFFFAOYSA-N 0.000 description 2
- 230000003042 antagnostic effect Effects 0.000 description 2
- 230000003276 anti-hypertensive effect Effects 0.000 description 2
- 125000003435 aroyl group Chemical group 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- 150000001540 azides Chemical class 0.000 description 2
- OSJRGDBEYARHLX-UHFFFAOYSA-N azido(trimethyl)stannane Chemical compound [N-]=[N+]=[N-].C[Sn+](C)C OSJRGDBEYARHLX-UHFFFAOYSA-N 0.000 description 2
- RMRMMALVBNUNHY-UHFFFAOYSA-N benzamide;trihydrochloride Chemical compound Cl.Cl.Cl.NC(=O)C1=CC=CC=C1 RMRMMALVBNUNHY-UHFFFAOYSA-N 0.000 description 2
- 125000001584 benzyloxycarbonyl group Chemical group C(=O)(OCC1=CC=CC=C1)* 0.000 description 2
- 230000027455 binding Effects 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- ILAHWRKJUDSMFH-UHFFFAOYSA-N boron tribromide Chemical compound BrB(Br)Br ILAHWRKJUDSMFH-UHFFFAOYSA-N 0.000 description 2
- 229940098773 bovine serum albumin Drugs 0.000 description 2
- 208000006752 brain edema Diseases 0.000 description 2
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 2
- 229910052794 bromium Inorganic materials 0.000 description 2
- 150000001649 bromium compounds Chemical class 0.000 description 2
- HQABUPZFAYXKJW-UHFFFAOYSA-N butan-1-amine Chemical compound CCCCN HQABUPZFAYXKJW-UHFFFAOYSA-N 0.000 description 2
- 125000000480 butynyl group Chemical group [*]C#CC([H])([H])C([H])([H])[H] 0.000 description 2
- 125000004063 butyryl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 150000004649 carbonic acid derivatives Chemical class 0.000 description 2
- 125000006297 carbonyl amino group Chemical group [H]N([*:2])C([*:1])=O 0.000 description 2
- 230000010261 cell growth Effects 0.000 description 2
- 206010008118 cerebral infarction Diseases 0.000 description 2
- 229910052801 chlorine Inorganic materials 0.000 description 2
- 150000001805 chlorine compounds Chemical class 0.000 description 2
- WORJEOGGNQDSOE-UHFFFAOYSA-N chloroform;methanol Chemical compound OC.ClC(Cl)Cl WORJEOGGNQDSOE-UHFFFAOYSA-N 0.000 description 2
- 239000002299 complementary DNA Substances 0.000 description 2
- GBRBMTNGQBKBQE-UHFFFAOYSA-L copper;diiodide Chemical compound I[Cu]I GBRBMTNGQBKBQE-UHFFFAOYSA-L 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 2
- JQVDAXLFBXTEQA-UHFFFAOYSA-N dibutylamine Chemical compound CCCCNCCCC JQVDAXLFBXTEQA-UHFFFAOYSA-N 0.000 description 2
- 125000006222 dimethylaminomethyl group Chemical group [H]C([H])([H])N(C([H])([H])[H])C([H])([H])* 0.000 description 2
- MKRTXPORKIRPDG-UHFFFAOYSA-N diphenylphosphoryl azide Chemical compound C=1C=CC=CC=1P(=O)(N=[N+]=[N-])C1=CC=CC=C1 MKRTXPORKIRPDG-UHFFFAOYSA-N 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 239000002934 diuretic Substances 0.000 description 2
- 230000008030 elimination Effects 0.000 description 2
- ZKQFHRVKCYFVCN-UHFFFAOYSA-N ethoxyethane;hexane Chemical compound CCOCC.CCCCCC ZKQFHRVKCYFVCN-UHFFFAOYSA-N 0.000 description 2
- OAYLNYINCPYISS-UHFFFAOYSA-N ethyl acetate;hexane Chemical compound CCCCCC.CCOC(C)=O OAYLNYINCPYISS-UHFFFAOYSA-N 0.000 description 2
- 230000002440 hepatic effect Effects 0.000 description 2
- 150000002391 heterocyclic compounds Chemical class 0.000 description 2
- 125000006038 hexenyl group Chemical group 0.000 description 2
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 2
- 238000005984 hydrogenation reaction Methods 0.000 description 2
- 150000004679 hydroxides Chemical class 0.000 description 2
- 125000004029 hydroxymethyl group Chemical group [H]OC([H])([H])* 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 150000007529 inorganic bases Chemical class 0.000 description 2
- KQNPFQTWMSNSAP-UHFFFAOYSA-N isobutyric acid Chemical compound CC(C)C(O)=O KQNPFQTWMSNSAP-UHFFFAOYSA-N 0.000 description 2
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 2
- 229910052744 lithium Inorganic materials 0.000 description 2
- NUJOXMJBOLGQSY-UHFFFAOYSA-N manganese dioxide Chemical compound O=[Mn]=O NUJOXMJBOLGQSY-UHFFFAOYSA-N 0.000 description 2
- 210000003584 mesangial cell Anatomy 0.000 description 2
- AWFPEEUEBVUOGG-UHFFFAOYSA-N methyl 3-methoxy-4-[(2-phenylmethoxybenzoyl)amino]benzoate Chemical compound COC1=CC(C(=O)OC)=CC=C1NC(=O)C1=CC=CC=C1OCC1=CC=CC=C1 AWFPEEUEBVUOGG-UHFFFAOYSA-N 0.000 description 2
- 125000006533 methyl amino methyl group Chemical group [H]N(C([H])([H])[H])C([H])([H])* 0.000 description 2
- RMAHPRNLQIRHIJ-UHFFFAOYSA-N methyl carbamimidate Chemical compound COC(N)=N RMAHPRNLQIRHIJ-UHFFFAOYSA-N 0.000 description 2
- 239000002480 mineral oil Substances 0.000 description 2
- 235000010446 mineral oil Nutrition 0.000 description 2
- 239000002808 molecular sieve Substances 0.000 description 2
- 125000002950 monocyclic group Chemical group 0.000 description 2
- 125000004573 morpholin-4-yl group Chemical group N1(CCOCC1)* 0.000 description 2
- 125000002757 morpholinyl group Chemical group 0.000 description 2
- NUBFOKFXAJQIFY-UHFFFAOYSA-N n-phenylbenzamide;dihydrochloride Chemical compound Cl.Cl.C=1C=CC=CC=1C(=O)NC1=CC=CC=C1 NUBFOKFXAJQIFY-UHFFFAOYSA-N 0.000 description 2
- QMMRZOWCJAIUJA-UHFFFAOYSA-L nickel dichloride Chemical compound Cl[Ni]Cl QMMRZOWCJAIUJA-UHFFFAOYSA-L 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Substances N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 2
- 230000009871 nonspecific binding Effects 0.000 description 2
- 150000007530 organic bases Chemical class 0.000 description 2
- XNOPRXBHLZRZKH-DSZYJQQASA-N oxytocin Chemical compound C([C@H]1C(=O)N[C@H](C(N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CSSC[C@H](N)C(=O)N1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)=O)[C@@H](C)CC)C1=CC=C(O)C=C1 XNOPRXBHLZRZKH-DSZYJQQASA-N 0.000 description 2
- 229960001723 oxytocin Drugs 0.000 description 2
- DPBLXKKOBLCELK-UHFFFAOYSA-N pentan-1-amine Chemical compound CCCCCN DPBLXKKOBLCELK-UHFFFAOYSA-N 0.000 description 2
- 125000002255 pentenyl group Chemical group C(=CCCC)* 0.000 description 2
- 239000000825 pharmaceutical preparation Substances 0.000 description 2
- UYWQUFXKFGHYNT-UHFFFAOYSA-N phenylmethyl ester of formic acid Natural products O=COCC1=CC=CC=C1 UYWQUFXKFGHYNT-UHFFFAOYSA-N 0.000 description 2
- FAIAAWCVCHQXDN-UHFFFAOYSA-N phosphorus trichloride Chemical compound ClP(Cl)Cl FAIAAWCVCHQXDN-UHFFFAOYSA-N 0.000 description 2
- 125000000612 phthaloyl group Chemical group C(C=1C(C(=O)*)=CC=CC1)(=O)* 0.000 description 2
- 125000004193 piperazinyl group Chemical group 0.000 description 2
- 125000005936 piperidyl group Chemical group 0.000 description 2
- FYRHIOVKTDQVFC-UHFFFAOYSA-M potassium phthalimide Chemical compound [K+].C1=CC=C2C(=O)[N-]C(=O)C2=C1 FYRHIOVKTDQVFC-UHFFFAOYSA-M 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 125000004368 propenyl group Chemical group C(=CC)* 0.000 description 2
- 125000001501 propionyl group Chemical group O=C([*])C([H])([H])C([H])([H])[H] 0.000 description 2
- WGYKZJWCGVVSQN-UHFFFAOYSA-N propylamine Chemical compound CCCN WGYKZJWCGVVSQN-UHFFFAOYSA-N 0.000 description 2
- 238000000159 protein binding assay Methods 0.000 description 2
- AOJFQRQNPXYVLM-UHFFFAOYSA-N pyridin-1-ium;chloride Chemical compound [Cl-].C1=CC=[NH+]C=C1 AOJFQRQNPXYVLM-UHFFFAOYSA-N 0.000 description 2
- 125000000246 pyrimidin-2-yl group Chemical group [H]C1=NC(*)=NC([H])=C1[H] 0.000 description 2
- 125000000719 pyrrolidinyl group Chemical group 0.000 description 2
- 238000002390 rotary evaporation Methods 0.000 description 2
- SMQUZDBALVYZAC-UHFFFAOYSA-N salicylaldehyde Chemical compound OC1=CC=CC=C1C=O SMQUZDBALVYZAC-UHFFFAOYSA-N 0.000 description 2
- URGAHOPLAPQHLN-UHFFFAOYSA-N sodium aluminosilicate Chemical compound [Na+].[Al+3].[O-][Si]([O-])=O.[O-][Si]([O-])=O URGAHOPLAPQHLN-UHFFFAOYSA-N 0.000 description 2
- 235000009518 sodium iodide Nutrition 0.000 description 2
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 2
- 239000006188 syrup Substances 0.000 description 2
- 235000020357 syrup Nutrition 0.000 description 2
- 238000010998 test method Methods 0.000 description 2
- 230000000699 topical effect Effects 0.000 description 2
- 125000005270 trialkylamine group Chemical group 0.000 description 2
- IMNIMPAHZVJRPE-UHFFFAOYSA-N triethylenediamine Chemical compound C1CN2CCN1CC2 IMNIMPAHZVJRPE-UHFFFAOYSA-N 0.000 description 2
- 125000004044 trifluoroacetyl group Chemical group FC(C(=O)*)(F)F 0.000 description 2
- JABYJIQOLGWMQW-UHFFFAOYSA-N undec-4-ene Chemical compound CCCCCCC=CCCC JABYJIQOLGWMQW-UHFFFAOYSA-N 0.000 description 2
- NQPDZGIKBAWPEJ-UHFFFAOYSA-N valeric acid Chemical compound CCCCC(O)=O NQPDZGIKBAWPEJ-UHFFFAOYSA-N 0.000 description 2
- 125000005023 xylyl group Chemical group 0.000 description 2
- NWZSZGALRFJKBT-KNIFDHDWSA-N (2s)-2,6-diaminohexanoic acid;(2s)-2-hydroxybutanedioic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O.NCCCC[C@H](N)C(O)=O NWZSZGALRFJKBT-KNIFDHDWSA-N 0.000 description 1
- MRXDGVXSWIXTQL-HYHFHBMOSA-N (2s)-2-[[(1s)-1-(2-amino-1,4,5,6-tetrahydropyrimidin-6-yl)-2-[[(2s)-4-methyl-1-oxo-1-[[(2s)-1-oxo-3-phenylpropan-2-yl]amino]pentan-2-yl]amino]-2-oxoethyl]carbamoylamino]-3-phenylpropanoic acid Chemical compound C([C@H](NC(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=1C=CC=CC=1)C=O)C1NC(N)=NCC1)C(O)=O)C1=CC=CC=C1 MRXDGVXSWIXTQL-HYHFHBMOSA-N 0.000 description 1
- PMHUSCHKTSTQEP-UHFFFAOYSA-N (4-carbamimidoylphenyl)methanesulfonyl fluoride Chemical compound NC(=N)C1=CC=C(CS(F)(=O)=O)C=C1 PMHUSCHKTSTQEP-UHFFFAOYSA-N 0.000 description 1
- WUWDGVKUXDZLNU-UHFFFAOYSA-M (4-methoxycarbonylphenyl)methyl-triphenylphosphanium;bromide Chemical compound [Br-].C1=CC(C(=O)OC)=CC=C1C[P+](C=1C=CC=CC=1)(C=1C=CC=CC=1)C1=CC=CC=C1 WUWDGVKUXDZLNU-UHFFFAOYSA-M 0.000 description 1
- GYPCWHHQAVLMKO-XXKQIVDLSA-N (7s,9s)-7-[(2r,4s,5s,6s)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-9-[(e)-n-[(1-hydroxy-2,2,6,6-tetramethylpiperidin-4-ylidene)amino]-c-methylcarbonimidoyl]-4-methoxy-8,10-dihydro-7h-tetracene-5,12-dione;hydrochloride Chemical group Cl.O([C@H]1C[C@@](O)(CC=2C(O)=C3C(=O)C=4C=CC=C(C=4C(=O)C3=C(O)C=21)OC)C(\C)=N\N=C1CC(C)(C)N(O)C(C)(C)C1)[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1 GYPCWHHQAVLMKO-XXKQIVDLSA-N 0.000 description 1
- 125000003161 (C1-C6) alkylene group Chemical group 0.000 description 1
- 125000004739 (C1-C6) alkylsulfonyl group Chemical group 0.000 description 1
- PUPZLCDOIYMWBV-BYPYZUCNSA-N (S)-butane-1,3-diol Chemical compound C[C@H](O)CCO PUPZLCDOIYMWBV-BYPYZUCNSA-N 0.000 description 1
- DYLIWHYUXAJDOJ-OWOJBTEDSA-N (e)-4-(6-aminopurin-9-yl)but-2-en-1-ol Chemical compound NC1=NC=NC2=C1N=CN2C\C=C\CO DYLIWHYUXAJDOJ-OWOJBTEDSA-N 0.000 description 1
- 125000004504 1,2,4-oxadiazolyl group Chemical group 0.000 description 1
- 125000004514 1,2,4-thiadiazolyl group Chemical group 0.000 description 1
- 125000004506 1,2,5-oxadiazolyl group Chemical group 0.000 description 1
- 125000004517 1,2,5-thiadiazolyl group Chemical group 0.000 description 1
- 125000001781 1,3,4-oxadiazolyl group Chemical group 0.000 description 1
- 125000004520 1,3,4-thiadiazolyl group Chemical group 0.000 description 1
- BDNKZNFMNDZQMI-UHFFFAOYSA-N 1,3-diisopropylcarbodiimide Chemical compound CC(C)N=C=NC(C)C BDNKZNFMNDZQMI-UHFFFAOYSA-N 0.000 description 1
- PTJSLCXRMMGRLY-UHFFFAOYSA-N 1-(2-phenoxyethyl)piperazine Chemical compound C=1C=CC=CC=1OCCN1CCNCC1 PTJSLCXRMMGRLY-UHFFFAOYSA-N 0.000 description 1
- HXBMIQJOSHZCFX-UHFFFAOYSA-N 1-(bromomethyl)-2-nitrobenzene Chemical compound [O-][N+](=O)C1=CC=CC=C1CBr HXBMIQJOSHZCFX-UHFFFAOYSA-N 0.000 description 1
- MOHYOXXOKFQHDC-UHFFFAOYSA-N 1-(chloromethyl)-4-methoxybenzene Chemical compound COC1=CC=C(CCl)C=C1 MOHYOXXOKFQHDC-UHFFFAOYSA-N 0.000 description 1
- DQXXKLYTOYMITI-UHFFFAOYSA-N 1-(dimethylamino)piperidin-2-one Chemical compound CN(C)N1CCCCC1=O DQXXKLYTOYMITI-UHFFFAOYSA-N 0.000 description 1
- LMDZBCPBFSXMTL-UHFFFAOYSA-N 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide Chemical compound CCN=C=NCCCN(C)C LMDZBCPBFSXMTL-UHFFFAOYSA-N 0.000 description 1
- WGCYRFWNGRMRJA-UHFFFAOYSA-N 1-ethylpiperazine Chemical compound CCN1CCNCC1 WGCYRFWNGRMRJA-UHFFFAOYSA-N 0.000 description 1
- BMVXCPBXGZKUPN-UHFFFAOYSA-N 1-hexanamine Chemical compound CCCCCCN BMVXCPBXGZKUPN-UHFFFAOYSA-N 0.000 description 1
- SNUSZUYTMHKCPM-UHFFFAOYSA-N 1-hydroxypyridin-2-one Chemical compound ON1C=CC=CC1=O SNUSZUYTMHKCPM-UHFFFAOYSA-N 0.000 description 1
- FXHRAKUEZPSMLJ-UHFFFAOYSA-N 1-methyl-1,4-diazepane Chemical compound CN1CCCNCC1 FXHRAKUEZPSMLJ-UHFFFAOYSA-N 0.000 description 1
- KJCVRFUGPWSIIH-UHFFFAOYSA-N 1-naphthol Chemical compound C1=CC=C2C(O)=CC=CC2=C1 KJCVRFUGPWSIIH-UHFFFAOYSA-N 0.000 description 1
- KJUGUADJHNHALS-UHFFFAOYSA-N 1H-tetrazole Substances C=1N=NNN=1 KJUGUADJHNHALS-UHFFFAOYSA-N 0.000 description 1
- 125000004206 2,2,2-trifluoroethyl group Chemical group [H]C([H])(*)C(F)(F)F 0.000 description 1
- YQTCQNIPQMJNTI-UHFFFAOYSA-N 2,2-dimethylpropan-1-one Chemical group CC(C)(C)[C]=O YQTCQNIPQMJNTI-UHFFFAOYSA-N 0.000 description 1
- JVSFQJZRHXAUGT-UHFFFAOYSA-N 2,2-dimethylpropanoyl chloride Chemical compound CC(C)(C)C(Cl)=O JVSFQJZRHXAUGT-UHFFFAOYSA-N 0.000 description 1
- SBASXUCJHJRPEV-UHFFFAOYSA-N 2-(2-methoxyethoxy)ethanol Chemical compound COCCOCCO SBASXUCJHJRPEV-UHFFFAOYSA-N 0.000 description 1
- VKJCJJYNVIYVQR-UHFFFAOYSA-N 2-(3-bromopropyl)isoindole-1,3-dione Chemical compound C1=CC=C2C(=O)N(CCCBr)C(=O)C2=C1 VKJCJJYNVIYVQR-UHFFFAOYSA-N 0.000 description 1
- OXQGTIUCKGYOAA-UHFFFAOYSA-N 2-Ethylbutanoic acid Chemical compound CCC(CC)C(O)=O OXQGTIUCKGYOAA-UHFFFAOYSA-N 0.000 description 1
- WOXFMYVTSLAQMO-UHFFFAOYSA-N 2-Pyridinemethanamine Chemical compound NCC1=CC=CC=N1 WOXFMYVTSLAQMO-UHFFFAOYSA-N 0.000 description 1
- VRPJIFMKZZEXLR-UHFFFAOYSA-N 2-[(2-methylpropan-2-yl)oxycarbonylamino]acetic acid Chemical compound CC(C)(C)OC(=O)NCC(O)=O VRPJIFMKZZEXLR-UHFFFAOYSA-N 0.000 description 1
- ZYHQGITXIJDDKC-UHFFFAOYSA-N 2-[2-(2-aminophenyl)ethyl]aniline Chemical group NC1=CC=CC=C1CCC1=CC=CC=C1N ZYHQGITXIJDDKC-UHFFFAOYSA-N 0.000 description 1
- KBFXRFXXWFZWJY-UHFFFAOYSA-N 2-[2-amino-3-[cyclohexyl(methyl)carbamoyl]phenoxy]acetic acid Chemical compound C=1C=CC(OCC(O)=O)=C(N)C=1C(=O)N(C)C1CCCCC1 KBFXRFXXWFZWJY-UHFFFAOYSA-N 0.000 description 1
- YPMSSELDKQIEBF-UHFFFAOYSA-N 2-[3-(1,3-dioxoisoindol-2-yl)propoxy]benzaldehyde Chemical compound O=CC1=CC=CC=C1OCCCN1C(=O)C2=CC=CC=C2C1=O YPMSSELDKQIEBF-UHFFFAOYSA-N 0.000 description 1
- YGDZTBBBQABGAV-UHFFFAOYSA-N 2-[3-(1,3-dioxoisoindol-2-yl)propoxy]benzoic acid Chemical compound OC(=O)C1=CC=CC=C1OCCCN1C(=O)C2=CC=CC=C2C1=O YGDZTBBBQABGAV-UHFFFAOYSA-N 0.000 description 1
- ZWZACDGGOIXVMJ-UHFFFAOYSA-N 2-[3-(9h-fluoren-9-ylmethoxycarbonylamino)propylsulfanyl]benzoic acid Chemical compound OC(=O)C1=CC=CC=C1SCCCNC(=O)OCC1C2=CC=CC=C2C2=CC=CC=C21 ZWZACDGGOIXVMJ-UHFFFAOYSA-N 0.000 description 1
- UXJPUJJUCKJHEE-UHFFFAOYSA-N 2-[3-[(4-methoxyphenyl)methoxy]propyl]benzenecarbothioic S-acid Chemical compound C1=CC(OC)=CC=C1COCCCC1=CC=CC=C1C(S)=O UXJPUJJUCKJHEE-UHFFFAOYSA-N 0.000 description 1
- LWUAMROXVQLJKA-UHFFFAOYSA-N 2-amino-3-chlorobenzoic acid Chemical compound NC1=C(Cl)C=CC=C1C(O)=O LWUAMROXVQLJKA-UHFFFAOYSA-N 0.000 description 1
- BZIBTFSENMUQHZ-UHFFFAOYSA-N 2-amino-N-(2-hydroxy-4-methylphenyl)-3-methoxy-N-methylbenzamide Chemical compound NC1=C(C(=O)N(C)C2=C(C=C(C=C2)C)O)C=CC=C1OC BZIBTFSENMUQHZ-UHFFFAOYSA-N 0.000 description 1
- HKEIBZMDZOBZAD-UHFFFAOYSA-N 2-amino-N-[2-[(4-cyanophenyl)methoxy]-4-methylphenyl]-3-methoxy-N-methylbenzamide Chemical compound NC1=C(C(=O)N(C)C2=C(C=C(C=C2)C)OCC2=CC=C(C=C2)C#N)C=CC=C1OC HKEIBZMDZOBZAD-UHFFFAOYSA-N 0.000 description 1
- IBQJLGZWXZSUFO-UHFFFAOYSA-N 2-amino-N-[2-[[4-(3-cyano-1,5-dimethylpyrrol-2-yl)phenyl]methoxy]-4-methylphenyl]-3-methoxy-N-methylbenzamide Chemical compound NC1=C(C(=O)N(C)C2=C(C=C(C=C2)C)OCC2=CC=C(C=C2)C=2N(C(=CC=2C#N)C)C)C=CC=C1OC IBQJLGZWXZSUFO-UHFFFAOYSA-N 0.000 description 1
- KJMPATKLRNIHSJ-UHFFFAOYSA-N 2-amino-N-methyl-N-[4-methyl-2-[6-(4-methylpiperazin-1-yl)-6-oxohexoxy]phenyl]-3-propoxybenzamide Chemical compound NC1=C(C(=O)N(C2=C(C=C(C=C2)C)OCCCCCC(=O)N2CCN(CC2)C)C)C=CC=C1OCCC KJMPATKLRNIHSJ-UHFFFAOYSA-N 0.000 description 1
- PFBNOFUOCBUSKW-UHFFFAOYSA-N 2-amino-n-cyclohexyl-n-methyl-3-phenylmethoxybenzamide Chemical compound C=1C=CC(OCC=2C=CC=CC=2)=C(N)C=1C(=O)N(C)C1CCCCC1 PFBNOFUOCBUSKW-UHFFFAOYSA-N 0.000 description 1
- QSOVSKMNRYAVJR-UHFFFAOYSA-N 2-benzoyloxybenzoic acid Chemical compound OC(=O)C1=CC=CC=C1OC(=O)C1=CC=CC=C1 QSOVSKMNRYAVJR-UHFFFAOYSA-N 0.000 description 1
- BTANRVKWQNVYAZ-UHFFFAOYSA-N 2-butanol Substances CCC(C)O BTANRVKWQNVYAZ-UHFFFAOYSA-N 0.000 description 1
- AVZBOAGCVKEESJ-UHFFFAOYSA-O 2-ethyl-1,2-benzoxazol-2-ium-7-ol Chemical class C1=CC(O)=C2O[N+](CC)=CC2=C1 AVZBOAGCVKEESJ-UHFFFAOYSA-O 0.000 description 1
- CFMZSMGAMPBRBE-UHFFFAOYSA-N 2-hydroxyisoindole-1,3-dione Chemical compound C1=CC=C2C(=O)N(O)C(=O)C2=C1 CFMZSMGAMPBRBE-UHFFFAOYSA-N 0.000 description 1
- LXBGSDVWAMZHDD-UHFFFAOYSA-N 2-methyl-1h-imidazole Chemical compound CC1=NC=CN1 LXBGSDVWAMZHDD-UHFFFAOYSA-N 0.000 description 1
- LBLYYCQCTBFVLH-UHFFFAOYSA-M 2-methylbenzenesulfonate Chemical compound CC1=CC=CC=C1S([O-])(=O)=O LBLYYCQCTBFVLH-UHFFFAOYSA-M 0.000 description 1
- YOETUEMZNOLGDB-UHFFFAOYSA-N 2-methylpropyl carbonochloridate Chemical compound CC(C)COC(Cl)=O YOETUEMZNOLGDB-UHFFFAOYSA-N 0.000 description 1
- CMWKITSNTDAEDT-UHFFFAOYSA-N 2-nitrobenzaldehyde Chemical compound [O-][N+](=O)C1=CC=CC=C1C=O CMWKITSNTDAEDT-UHFFFAOYSA-N 0.000 description 1
- 125000004278 2-oxazolin-2-yl group Chemical group [H]C1([H])OC(*)=NC1([H])[H] 0.000 description 1
- 125000003504 2-oxazolinyl group Chemical group O1C(=NCC1)* 0.000 description 1
- GMOYUTKNPLBTMT-UHFFFAOYSA-N 2-phenylmethoxybenzoic acid Chemical compound OC(=O)C1=CC=CC=C1OCC1=CC=CC=C1 GMOYUTKNPLBTMT-UHFFFAOYSA-N 0.000 description 1
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 description 1
- 125000001494 2-propynyl group Chemical group [H]C#CC([H])([H])* 0.000 description 1
- UKVQBONVSSLJBB-UHFFFAOYSA-N 2-pyridin-2-ylacetonitrile Chemical compound N#CCC1=CC=CC=N1 UKVQBONVSSLJBB-UHFFFAOYSA-N 0.000 description 1
- JMTMSDXUXJISAY-UHFFFAOYSA-N 2H-benzotriazol-4-ol Chemical compound OC1=CC=CC2=C1N=NN2 JMTMSDXUXJISAY-UHFFFAOYSA-N 0.000 description 1
- SDXAWLJRERMRKF-UHFFFAOYSA-N 3,5-dimethyl-1h-pyrazole Chemical class CC=1C=C(C)NN=1 SDXAWLJRERMRKF-UHFFFAOYSA-N 0.000 description 1
- NSHAOELVDPKZIC-UHFFFAOYSA-N 3-(2-ethyl-1,2-oxazol-2-ium-5-yl)benzenesulfonic acid;hydroxide Chemical compound [OH-].O1[N+](CC)=CC=C1C1=CC=CC(S(O)(=O)=O)=C1 NSHAOELVDPKZIC-UHFFFAOYSA-N 0.000 description 1
- RLTZJBKOOIQKNR-UHFFFAOYSA-N 3-(2-nitrophenoxy)propan-1-ol Chemical compound OCCCOC1=CC=CC=C1[N+]([O-])=O RLTZJBKOOIQKNR-UHFFFAOYSA-N 0.000 description 1
- YNJSNEKCXVFDKW-UHFFFAOYSA-N 3-(5-amino-1h-indol-3-yl)-2-azaniumylpropanoate Chemical compound C1=C(N)C=C2C(CC(N)C(O)=O)=CNC2=C1 YNJSNEKCXVFDKW-UHFFFAOYSA-N 0.000 description 1
- YGMQDBCXHASOHO-UHFFFAOYSA-N 3-bromopropan-1-amine;hydrochloride Chemical compound Cl.NCCCBr YGMQDBCXHASOHO-UHFFFAOYSA-N 0.000 description 1
- JPCISVSOTKMFPG-UHFFFAOYSA-N 3-methoxy-2-methylbenzoic acid Chemical compound COC1=CC=CC(C(O)=O)=C1C JPCISVSOTKMFPG-UHFFFAOYSA-N 0.000 description 1
- ZOUGCFYSFRCRBI-UHFFFAOYSA-N 3-methoxy-n-methyl-n-(4-methyl-2-phenylmethoxyphenyl)-4-nitrobenzamide Chemical compound C1=C([N+]([O-])=O)C(OC)=CC(C(=O)N(C)C=2C(=CC(C)=CC=2)OCC=2C=CC=CC=2)=C1 ZOUGCFYSFRCRBI-UHFFFAOYSA-N 0.000 description 1
- OVJWELUCDVYOCD-UHFFFAOYSA-N 3-methoxy-n-methyl-n-[4-methyl-2-[6-(4-methylpiperazin-1-yl)-6-oxohexoxy]phenyl]-4-[(2-nitrophenyl)methoxy]benzamide Chemical compound COC1=CC(C(=O)N(C)C=2C(=CC(C)=CC=2)OCCCCCC(=O)N2CCN(C)CC2)=CC=C1OCC1=CC=CC=C1[N+]([O-])=O OVJWELUCDVYOCD-UHFFFAOYSA-N 0.000 description 1
- VYTNKNIWGFQFEU-UHFFFAOYSA-N 3-methoxy-n-methyl-n-[4-methyl-2-[6-(4-methylpiperazin-1-yl)-6-oxohexoxy]phenyl]-4-[(2-nitrophenyl)sulfonylamino]benzamide Chemical compound COC1=CC(C(=O)N(C)C=2C(=CC(C)=CC=2)OCCCCCC(=O)N2CCN(C)CC2)=CC=C1NS(=O)(=O)C1=CC=CC=C1[N+]([O-])=O VYTNKNIWGFQFEU-UHFFFAOYSA-N 0.000 description 1
- YEAHPODOZLVGAA-UHFFFAOYSA-N 3-methoxy-n-methyl-n-[4-methyl-2-[6-(4-methylpiperazin-1-yl)-6-oxohexoxy]phenyl]-4-nitrobenzamide Chemical compound C1=C([N+]([O-])=O)C(OC)=CC(C(=O)N(C)C=2C(=CC(C)=CC=2)OCCCCCC(=O)N2CCN(C)CC2)=C1 YEAHPODOZLVGAA-UHFFFAOYSA-N 0.000 description 1
- QMYGFTJCQFEDST-UHFFFAOYSA-N 3-methoxybutyl acetate Chemical group COC(C)CCOC(C)=O QMYGFTJCQFEDST-UHFFFAOYSA-N 0.000 description 1
- 125000003349 3-pyridyl group Chemical group N1=C([H])C([*])=C([H])C([H])=C1[H] 0.000 description 1
- IGIJSFNBEUBMGB-UHFFFAOYSA-N 4-(cyclohexyliminomethylideneamino)-n,n-diethylcyclohexan-1-amine Chemical compound C1CC(N(CC)CC)CCC1N=C=NC1CCCCC1 IGIJSFNBEUBMGB-UHFFFAOYSA-N 0.000 description 1
- GWRSATNRNFYMDI-UHFFFAOYSA-N 4-[(9-cyclopentyl-7,7-difluoro-5-methyl-6-oxo-8h-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-2-fluoro-5-methoxy-n-(1-methylpiperidin-4-yl)benzamide Chemical compound FC=1C=C(NC=2N=C3N(C4CCCC4)CC(F)(F)C(=O)N(C)C3=CN=2)C(OC)=CC=1C(=O)NC1CCN(C)CC1 GWRSATNRNFYMDI-UHFFFAOYSA-N 0.000 description 1
- IXOTYFXZGMUETC-UHFFFAOYSA-N 4-[[2-(3-aminopropoxy)benzoyl]amino]-3-methoxy-n-methyl-n-[4-methyl-2-[6-(4-methylpiperazin-1-yl)-6-oxohexoxy]phenyl]benzamide;sulfuric acid Chemical compound OS(O)(=O)=O.COC1=CC(C(=O)N(C)C=2C(=CC(C)=CC=2)OCCCCCC(=O)N2CCN(C)CC2)=CC=C1NC(=O)C1=CC=CC=C1OCCCN IXOTYFXZGMUETC-UHFFFAOYSA-N 0.000 description 1
- YRLWVUHISACBJQ-UHFFFAOYSA-N 4-[[2-(3-aminopropoxy)benzoyl]amino]-3-methoxy-n-methyl-n-[4-methyl-2-[[4-(2h-tetrazol-5-yl)phenyl]methoxy]phenyl]benzamide Chemical compound COC1=CC(C(=O)N(C)C=2C(=CC(C)=CC=2)OCC=2C=CC(=CC=2)C=2NN=NN=2)=CC=C1NC(=O)C1=CC=CC=C1OCCCN YRLWVUHISACBJQ-UHFFFAOYSA-N 0.000 description 1
- JHBDKWINKRQNNI-UHFFFAOYSA-N 4-[[2-(3-aminopropoxy)benzoyl]amino]-n-(4-hydroxyphenyl)-3-methoxy-n-methylbenzamide;hydrochloride Chemical compound Cl.COC1=CC(C(=O)N(C)C=2C=CC(O)=CC=2)=CC=C1NC(=O)C1=CC=CC=C1OCCCN JHBDKWINKRQNNI-UHFFFAOYSA-N 0.000 description 1
- IYSSRZUDBBVIOY-UHFFFAOYSA-N 4-[[2-(dimethylamino)-5-methylphenoxy]methyl]benzoic acid Chemical compound CN(C)C1=CC=C(C)C=C1OCC1=CC=C(C(O)=O)C=C1 IYSSRZUDBBVIOY-UHFFFAOYSA-N 0.000 description 1
- WYCBNFCSEZBPMC-YTTGMZPUSA-N 4-[[2-[(2s)-4-(1,3-dioxoisoindol-2-yl)butan-2-yl]oxybenzoyl]amino]-3-methoxy-n-methyl-n-[4-methyl-2-[6-(4-methylpiperazin-1-yl)-6-oxohexoxy]phenyl]benzamide Chemical compound C=1C=C(NC(=O)C=2C(=CC=CC=2)O[C@@H](C)CCN2C(C3=CC=CC=C3C2=O)=O)C(OC)=CC=1C(=O)N(C)C1=CC=C(C)C=C1OCCCCCC(=O)N1CCN(C)CC1 WYCBNFCSEZBPMC-YTTGMZPUSA-N 0.000 description 1
- JBNXJGINCVDQLN-NDEPHWFRSA-N 4-[[2-[(2s)-4-aminobutan-2-yl]oxybenzoyl]amino]-3-methoxy-n-methyl-n-[4-methyl-2-[6-(4-methylpiperazin-1-yl)-6-oxohexoxy]phenyl]benzamide Chemical compound COC1=CC(C(=O)N(C)C=2C(=CC(C)=CC=2)OCCCCCC(=O)N2CCN(C)CC2)=CC=C1NC(=O)C1=CC=CC=C1O[C@@H](C)CCN JBNXJGINCVDQLN-NDEPHWFRSA-N 0.000 description 1
- KRDXFJBRYJCMDZ-UHFFFAOYSA-N 4-[[2-[(4-amino-3-methoxybenzoyl)-methylamino]-5-methylphenoxy]methyl]benzoic acid Chemical compound C1=C(N)C(OC)=CC(C(=O)N(C)C=2C(=CC(C)=CC=2)OCC=2C=CC(=CC=2)C(O)=O)=C1 KRDXFJBRYJCMDZ-UHFFFAOYSA-N 0.000 description 1
- XJPRMVXDOZXOHM-UHFFFAOYSA-N 4-[[2-[3-(diaminomethylideneamino)propoxy]benzoyl]amino]-n-[2-[6-[4-(dimethylamino)piperidin-1-yl]-6-oxohexoxy]-4-methylphenyl]-3-methoxy-n-methylbenzamide Chemical compound COC1=CC(C(=O)N(C)C=2C(=CC(C)=CC=2)OCCCCCC(=O)N2CCC(CC2)N(C)C)=CC=C1NC(=O)C1=CC=CC=C1OCCCNC(N)=N XJPRMVXDOZXOHM-UHFFFAOYSA-N 0.000 description 1
- HVCBWFSEPIDQPI-UHFFFAOYSA-N 4-amino-3-methoxy-n-methyl-n-(4-methyl-2-phenylmethoxyphenyl)benzamide Chemical compound C1=C(N)C(OC)=CC(C(=O)N(C)C=2C(=CC(C)=CC=2)OCC=2C=CC=CC=2)=C1 HVCBWFSEPIDQPI-UHFFFAOYSA-N 0.000 description 1
- LPWPWVGGLLEBFA-UHFFFAOYSA-N 4-amino-n-[2-[[4-(2-hydroxyethylcarbamoyl)phenyl]methoxy]-4-methylphenyl]-3-methoxy-n-methylbenzamide Chemical compound C1=C(N)C(OC)=CC(C(=O)N(C)C=2C(=CC(C)=CC=2)OCC=2C=CC(=CC=2)C(=O)NCCO)=C1 LPWPWVGGLLEBFA-UHFFFAOYSA-N 0.000 description 1
- GWBCRVLJPQPXMM-UHFFFAOYSA-N 4-amino-n-[2-[[4-(4,5-dihydro-1,3-oxazol-2-yl)phenyl]methoxy]-4-methylphenyl]-3-methoxy-n-methylbenzamide Chemical compound C1=C(N)C(OC)=CC(C(=O)N(C)C=2C(=CC(C)=CC=2)OCC=2C=CC(=CC=2)C=2OCCN=2)=C1 GWBCRVLJPQPXMM-UHFFFAOYSA-N 0.000 description 1
- ALYNCZNDIQEVRV-UHFFFAOYSA-N 4-aminobenzoic acid Chemical compound NC1=CC=C(C(O)=O)C=C1 ALYNCZNDIQEVRV-UHFFFAOYSA-N 0.000 description 1
- WVBXPFZPLODXRL-UHFFFAOYSA-N 4-hydroxy-3-methoxy-n-methyl-n-[4-methyl-2-[6-(4-methylpiperazin-1-yl)-6-oxohexoxy]phenyl]benzamide Chemical compound C1=C(O)C(OC)=CC(C(=O)N(C)C=2C(=CC(C)=CC=2)OCCCCCC(=O)N2CCN(C)CC2)=C1 WVBXPFZPLODXRL-UHFFFAOYSA-N 0.000 description 1
- 125000004217 4-methoxybenzyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1OC([H])([H])[H])C([H])([H])* 0.000 description 1
- UQRONKZLYKUEMO-UHFFFAOYSA-N 4-methyl-1-(2,4,6-trimethylphenyl)pent-4-en-2-one Chemical group CC(=C)CC(=O)Cc1c(C)cc(C)cc1C UQRONKZLYKUEMO-UHFFFAOYSA-N 0.000 description 1
- 150000000565 5-membered heterocyclic compounds Chemical class 0.000 description 1
- 125000004070 6 membered heterocyclic group Chemical group 0.000 description 1
- UQHGQMZBAUQGKD-UHFFFAOYSA-N 6-(2-amino-5-methylphenoxy)-1-[4-(dimethylamino)piperidin-1-yl]hexan-1-one Chemical compound C1CC(N(C)C)CCN1C(=O)CCCCCOC1=CC(C)=CC=C1N UQHGQMZBAUQGKD-UHFFFAOYSA-N 0.000 description 1
- PQCCSGKLVVVYJL-UHFFFAOYSA-N 6-[5-methyl-2-(methylamino)phenoxy]-1-(4-methylpiperazin-1-yl)hexan-1-one Chemical compound CNC1=CC=C(C)C=C1OCCCCCC(=O)N1CCN(C)CC1 PQCCSGKLVVVYJL-UHFFFAOYSA-N 0.000 description 1
- 150000000644 6-membered heterocyclic compounds Chemical class 0.000 description 1
- XWBHEIFHCNVXPS-UHFFFAOYSA-N 9h-fluoren-9-ylmethyl n-(3-bromopropyl)carbamate Chemical compound C1=CC=C2C(COC(=O)NCCCBr)C3=CC=CC=C3C2=C1 XWBHEIFHCNVXPS-UHFFFAOYSA-N 0.000 description 1
- USFZMSVCRYTOJT-UHFFFAOYSA-N Ammonium acetate Chemical compound N.CC(O)=O USFZMSVCRYTOJT-UHFFFAOYSA-N 0.000 description 1
- 239000005695 Ammonium acetate Substances 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- 108010001478 Bacitracin Proteins 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 description 1
- GJKVPYFGAIYMIL-UHFFFAOYSA-N C(C)(C)(C)OC(=O)NCCCOC1=C(C(=O)C2=C(C(=C(C(=O)O)C=C2)N)OC)C=CC=C1 Chemical compound C(C)(C)(C)OC(=O)NCCCOC1=C(C(=O)C2=C(C(=C(C(=O)O)C=C2)N)OC)C=CC=C1 GJKVPYFGAIYMIL-UHFFFAOYSA-N 0.000 description 1
- WOTDNTVUMNLFBP-UHFFFAOYSA-N C(C)(C)(C)OC(=O)NCCCOC1=C(C(=O)C=2SC(=CC2N)C(=O)O)C=CC=C1 Chemical compound C(C)(C)(C)OC(=O)NCCCOC1=C(C(=O)C=2SC(=CC2N)C(=O)O)C=CC=C1 WOTDNTVUMNLFBP-UHFFFAOYSA-N 0.000 description 1
- GBLBTHDECFRYIB-UHFFFAOYSA-N C(C1=CC=CC=C1)OC1=C(C(=O)C2=C(C(=C(C(=O)O)C=C2)[N+](=O)[O-])N)C=CC=C1 Chemical compound C(C1=CC=CC=C1)OC1=C(C(=O)C2=C(C(=C(C(=O)O)C=C2)[N+](=O)[O-])N)C=CC=C1 GBLBTHDECFRYIB-UHFFFAOYSA-N 0.000 description 1
- WUXFQAMFNLUULI-UHFFFAOYSA-N C(C1=CC=CC=C1)OC1=C(C(=O)C2=NC=C(C=C2N)C(=O)O)C=CC=C1 Chemical compound C(C1=CC=CC=C1)OC1=C(C(=O)C2=NC=C(C=C2N)C(=O)O)C=CC=C1 WUXFQAMFNLUULI-UHFFFAOYSA-N 0.000 description 1
- 125000003601 C2-C6 alkynyl group Chemical group 0.000 description 1
- GRIOIFHDICFMOC-UHFFFAOYSA-N CC(C=C1)=CC(OCCCCNC(N(CC2)CCC2N(C)C)=O)=C1N(C)C(C(C=CC=C1OC)=C1N)=O Chemical compound CC(C=C1)=CC(OCCCCNC(N(CC2)CCC2N(C)C)=O)=C1N(C)C(C(C=CC=C1OC)=C1N)=O GRIOIFHDICFMOC-UHFFFAOYSA-N 0.000 description 1
- KTKUKWXLLNPPJZ-UHFFFAOYSA-N CC(C=C1)=CC(OCCCCNC(N)=N)=C1N(C)C(C(C=CC=C1OC)=C1N)=O Chemical compound CC(C=C1)=CC(OCCCCNC(N)=N)=C1N(C)C(C(C=CC=C1OC)=C1N)=O KTKUKWXLLNPPJZ-UHFFFAOYSA-N 0.000 description 1
- NJVVKYISYXFJAY-UHFFFAOYSA-N CN(CCCOC1=C(C(=O)C2=C(C(=C(C(=O)O)C=C2)N)OC)C=CC=C1)C(=O)OC(C)(C)C Chemical compound CN(CCCOC1=C(C(=O)C2=C(C(=C(C(=O)O)C=C2)N)OC)C=CC=C1)C(=O)OC(C)(C)C NJVVKYISYXFJAY-UHFFFAOYSA-N 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- OLVPQBGMUGIKIW-UHFFFAOYSA-N Chymostatin Natural products C=1C=CC=CC=1CC(C=O)NC(=O)C(C(C)CC)NC(=O)C(C1NC(N)=NCC1)NC(=O)NC(C(O)=O)CC1=CC=CC=C1 OLVPQBGMUGIKIW-UHFFFAOYSA-N 0.000 description 1
- AZUARVZCHOIRCX-UHFFFAOYSA-N Cl.Cl.NC1=C(C(=O)N(C)C2=C(C=C(C=C2)C)OCC2=CC=C(C=C2)C2=NC=CC=C2)C=CC=C1OC Chemical compound Cl.Cl.NC1=C(C(=O)N(C)C2=C(C=C(C=C2)C)OCC2=CC=C(C=C2)C2=NC=CC=C2)C=CC=C1OC AZUARVZCHOIRCX-UHFFFAOYSA-N 0.000 description 1
- UWYWCQDPBDGXCT-UHFFFAOYSA-N Cl.Cl.NC1=C(C(=O)N(C)C2=C(C=C(C=C2)C)OCCCCNC(CCN)=O)C=CC=C1OC Chemical compound Cl.Cl.NC1=C(C(=O)N(C)C2=C(C=C(C=C2)C)OCCCCNC(CCN)=O)C=CC=C1OC UWYWCQDPBDGXCT-UHFFFAOYSA-N 0.000 description 1
- FSRULAQWVFPOON-UHFFFAOYSA-N Cl.NC1=C(C(=O)N(C2CCCCC2)C)C=CC=C1OCC(=O)O Chemical compound Cl.NC1=C(C(=O)N(C2CCCCC2)C)C=CC=C1OCC(=O)O FSRULAQWVFPOON-UHFFFAOYSA-N 0.000 description 1
- 241000699802 Cricetulus griseus Species 0.000 description 1
- XTHFKEDIFFGKHM-UHFFFAOYSA-N Dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 description 1
- 241000255925 Diptera Species 0.000 description 1
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 1
- 239000005977 Ethylene Substances 0.000 description 1
- KRHYYFGTRYWZRS-UHFFFAOYSA-N Fluorane Chemical compound F KRHYYFGTRYWZRS-UHFFFAOYSA-N 0.000 description 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 1
- BDAGIHXWWSANSR-UHFFFAOYSA-M Formate Chemical compound [O-]C=O BDAGIHXWWSANSR-UHFFFAOYSA-M 0.000 description 1
- WRYCSMQKUKOKBP-UHFFFAOYSA-N Imidazolidine Chemical compound C1CNCN1 WRYCSMQKUKOKBP-UHFFFAOYSA-N 0.000 description 1
- 239000003810 Jones reagent Substances 0.000 description 1
- 239000001358 L(+)-tartaric acid Substances 0.000 description 1
- 235000011002 L(+)-tartaric acid Nutrition 0.000 description 1
- FEWJPZIEWOKRBE-LWMBPPNESA-N L-(+)-Tartaric acid Natural products OC(=O)[C@@H](O)[C@H](O)C(O)=O FEWJPZIEWOKRBE-LWMBPPNESA-N 0.000 description 1
- GDBQQVLCIARPGH-UHFFFAOYSA-N Leupeptin Natural products CC(C)CC(NC(C)=O)C(=O)NC(CC(C)C)C(=O)NC(C=O)CCCN=C(N)N GDBQQVLCIARPGH-UHFFFAOYSA-N 0.000 description 1
- 239000012448 Lithium borohydride Substances 0.000 description 1
- 239000012359 Methanesulfonyl chloride Substances 0.000 description 1
- PGBFYLVIMDQYMS-UHFFFAOYSA-N Methyl thiophene-2-carboxylate Chemical compound COC(=O)C1=CC=CS1 PGBFYLVIMDQYMS-UHFFFAOYSA-N 0.000 description 1
- 241001024304 Mino Species 0.000 description 1
- 101100521345 Mus musculus Prop1 gene Proteins 0.000 description 1
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 description 1
- JPMQCBWJZWKVBM-UHFFFAOYSA-N N-(2-hydroxyphenyl)-N-methyl-4-nitrobenzamide Chemical compound C=1C=CC=C(O)C=1N(C)C(=O)C1=CC=C([N+]([O-])=O)C=C1 JPMQCBWJZWKVBM-UHFFFAOYSA-N 0.000 description 1
- NQTADLQHYWFPDB-UHFFFAOYSA-N N-Hydroxysuccinimide Chemical compound ON1C(=O)CCC1=O NQTADLQHYWFPDB-UHFFFAOYSA-N 0.000 description 1
- PHSPJQZRQAJPPF-UHFFFAOYSA-N N-alpha-Methylhistamine Chemical compound CNCCC1=CN=CN1 PHSPJQZRQAJPPF-UHFFFAOYSA-N 0.000 description 1
- WXVLIIDDWFGYCV-UHFFFAOYSA-N N-benzoylanthranilic acid Chemical compound OC(=O)C1=CC=CC=C1NC(=O)C1=CC=CC=C1 WXVLIIDDWFGYCV-UHFFFAOYSA-N 0.000 description 1
- XNPOFXIBHOVFFH-UHFFFAOYSA-N N-cyclohexyl-N'-(2-(4-morpholinyl)ethyl)carbodiimide Chemical compound C1CCCCC1N=C=NCCN1CCOCC1 XNPOFXIBHOVFFH-UHFFFAOYSA-N 0.000 description 1
- UEEJHVSXFDXPFK-UHFFFAOYSA-N N-dimethylaminoethanol Chemical compound CN(C)CCO UEEJHVSXFDXPFK-UHFFFAOYSA-N 0.000 description 1
- IUJKGWILMDPYCA-UHFFFAOYSA-N NC1=C(C(=O)N(C)C2=C(C=C(C=C2)C)OC(C)=O)C=CC=C1OC Chemical compound NC1=C(C(=O)N(C)C2=C(C=C(C=C2)C)OC(C)=O)C=CC=C1OC IUJKGWILMDPYCA-UHFFFAOYSA-N 0.000 description 1
- UOTVOMHURDFGJM-UHFFFAOYSA-N NC1=C(C(=O)N(C)C2=C(C=C(C=C2)C)OCC2=CC=C(C=C2)C=2OCCN2)C=CC=C1OC Chemical compound NC1=C(C(=O)N(C)C2=C(C=C(C=C2)C)OCC2=CC=C(C=C2)C=2OCCN2)C=CC=C1OC UOTVOMHURDFGJM-UHFFFAOYSA-N 0.000 description 1
- BXAMMXCNRUHWNL-UHFFFAOYSA-N NC1=C(C(=O)N(C)C2=C(C=C(C=C2)C)OCC2=CC=C(C=N2)C(=O)N2CCN(CC2)C)C=CC=C1OC Chemical compound NC1=C(C(=O)N(C)C2=C(C=C(C=C2)C)OCC2=CC=C(C=N2)C(=O)N2CCN(CC2)C)C=CC=C1OC BXAMMXCNRUHWNL-UHFFFAOYSA-N 0.000 description 1
- YSNKKHFAZQFFCG-UHFFFAOYSA-N NC1=C(C(=O)N(C)C2=C(C=C(C=C2)C)OCC2=CC=C(C=N2)C(=O)O)C=CC=C1OC Chemical compound NC1=C(C(=O)N(C)C2=C(C=C(C=C2)C)OCC2=CC=C(C=N2)C(=O)O)C=CC=C1OC YSNKKHFAZQFFCG-UHFFFAOYSA-N 0.000 description 1
- YXQWTQNYGSMBAO-UHFFFAOYSA-N NC1=C(C(=O)N(C)C2=C(C=C(C=C2)C)OCCCCN2C(C=3C(C2=O)=CC=CC3)=O)C=CC=C1OC Chemical compound NC1=C(C(=O)N(C)C2=C(C=C(C=C2)C)OCCCCN2C(C=3C(C2=O)=CC=CC3)=O)C=CC=C1OC YXQWTQNYGSMBAO-UHFFFAOYSA-N 0.000 description 1
- RPEQUVJYKYSYPD-UHFFFAOYSA-N NC1=C(C(=O)N(C)C2=C(C=C(C=C2)C)OCCCCNC(=O)C2CCNCC2)C=CC=C1OC Chemical compound NC1=C(C(=O)N(C)C2=C(C=C(C=C2)C)OCCCCNC(=O)C2CCNCC2)C=CC=C1OC RPEQUVJYKYSYPD-UHFFFAOYSA-N 0.000 description 1
- LFLROOAALOMKDK-UHFFFAOYSA-N NC1=C(C(=O)N(C)C2=C(C=C(C=C2)C)OCCCCNC(=O)OCCCN(C)C)C=CC=C1OC Chemical compound NC1=C(C(=O)N(C)C2=C(C=C(C=C2)C)OCCCCNC(=O)OCCCN(C)C)C=CC=C1OC LFLROOAALOMKDK-UHFFFAOYSA-N 0.000 description 1
- GZYWZPYAVMDUOO-UHFFFAOYSA-N NC1=C(C(=O)N(C)C2=C(C=CC=C2)COCC2=CC=C(C=C2)C=2OCCN2)C=CC=C1OC Chemical compound NC1=C(C(=O)N(C)C2=C(C=CC=C2)COCC2=CC=C(C=C2)C=2OCCN2)C=CC=C1OC GZYWZPYAVMDUOO-UHFFFAOYSA-N 0.000 description 1
- VYEHXFFNSCSHID-UHFFFAOYSA-N O=C(C1=CC=CC=C1)NC1=CC=CC=C1.Cl.Cl.Cl Chemical compound O=C(C1=CC=CC=C1)NC1=CC=CC=C1.Cl.Cl.Cl VYEHXFFNSCSHID-UHFFFAOYSA-N 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- YGYAWVDWMABLBF-UHFFFAOYSA-N Phosgene Chemical compound ClC(Cl)=O YGYAWVDWMABLBF-UHFFFAOYSA-N 0.000 description 1
- 229920000388 Polyphosphate Polymers 0.000 description 1
- 108700017836 Prophet of Pit-1 Proteins 0.000 description 1
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical group [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- FZWLAAWBMGSTSO-UHFFFAOYSA-N Thiazole Chemical compound C1=CSC=N1 FZWLAAWBMGSTSO-UHFFFAOYSA-N 0.000 description 1
- 229910021626 Tin(II) chloride Inorganic materials 0.000 description 1
- DTQVDTLACAAQTR-UHFFFAOYSA-M Trifluoroacetate Chemical compound [O-]C(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-M 0.000 description 1
- HELSCPRKLIJMBU-JTQLQIEISA-N [(3s)-3-hydroxybutyl] 4-methylbenzenesulfonate Chemical compound C[C@H](O)CCOS(=O)(=O)C1=CC=C(C)C=C1 HELSCPRKLIJMBU-JTQLQIEISA-N 0.000 description 1
- QPQGTZMAQRXCJW-UHFFFAOYSA-N [chloro(phenyl)phosphoryl]benzene Chemical compound C=1C=CC=CC=1P(=O)(Cl)C1=CC=CC=C1 QPQGTZMAQRXCJW-UHFFFAOYSA-N 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 238000005917 acylation reaction Methods 0.000 description 1
- 125000005041 acyloxyalkyl group Chemical group 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- 150000007933 aliphatic carboxylic acids Chemical class 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 229910000288 alkali metal carbonate Inorganic materials 0.000 description 1
- 150000008041 alkali metal carbonates Chemical class 0.000 description 1
- 229910000102 alkali metal hydride Inorganic materials 0.000 description 1
- 150000008046 alkali metal hydrides Chemical class 0.000 description 1
- 229910001516 alkali metal iodide Inorganic materials 0.000 description 1
- 150000001447 alkali salts Chemical class 0.000 description 1
- 125000005153 alkyl sulfamoyl group Chemical group 0.000 description 1
- HSFWRNGVRCDJHI-UHFFFAOYSA-N alpha-acetylene Natural products C#C HSFWRNGVRCDJHI-UHFFFAOYSA-N 0.000 description 1
- 229940064734 aminobenzoate Drugs 0.000 description 1
- 125000004202 aminomethyl group Chemical group [H]N([H])C([H])([H])* 0.000 description 1
- 150000003927 aminopyridines Chemical class 0.000 description 1
- 235000019257 ammonium acetate Nutrition 0.000 description 1
- 229940043376 ammonium acetate Drugs 0.000 description 1
- VZTDIZULWFCMLS-UHFFFAOYSA-N ammonium formate Chemical compound [NH4+].[O-]C=O VZTDIZULWFCMLS-UHFFFAOYSA-N 0.000 description 1
- 150000004945 aromatic hydrocarbons Chemical class 0.000 description 1
- 125000005098 aryl alkoxy carbonyl group Chemical group 0.000 description 1
- 125000003710 aryl alkyl group Chemical group 0.000 description 1
- 125000005161 aryl oxy carbonyl group Chemical group 0.000 description 1
- 125000004429 atom Chemical group 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical group [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- CBHOOMGKXCMKIR-UHFFFAOYSA-N azane;methanol Chemical compound N.OC CBHOOMGKXCMKIR-UHFFFAOYSA-N 0.000 description 1
- 229960003071 bacitracin Drugs 0.000 description 1
- 229930184125 bacitracin Natural products 0.000 description 1
- CLKOFPXJLQSYAH-ABRJDSQDSA-N bacitracin A Chemical compound C1SC([C@@H](N)[C@@H](C)CC)=N[C@@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]1C(=O)N[C@H](CCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CC=2N=CNC=2)C(=O)N[C@H](CC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)NCCCC1 CLKOFPXJLQSYAH-ABRJDSQDSA-N 0.000 description 1
- ASEYGLHOKYYOPX-UHFFFAOYSA-N benzamide;dihydrochloride Chemical compound Cl.Cl.NC(=O)C1=CC=CC=C1 ASEYGLHOKYYOPX-UHFFFAOYSA-N 0.000 description 1
- ZVSKZLHKADLHSD-UHFFFAOYSA-N benzanilide Chemical compound C=1C=CC=CC=1C(=O)NC1=CC=CC=C1 ZVSKZLHKADLHSD-UHFFFAOYSA-N 0.000 description 1
- 229940077388 benzenesulfonate Drugs 0.000 description 1
- SRSXLGNVWSONIS-UHFFFAOYSA-M benzenesulfonate Chemical compound [O-]S(=O)(=O)C1=CC=CC=C1 SRSXLGNVWSONIS-UHFFFAOYSA-M 0.000 description 1
- 125000003785 benzimidazolyl group Chemical group N1=C(NC2=C1C=CC=C2)* 0.000 description 1
- 125000005605 benzo group Chemical group 0.000 description 1
- 125000002047 benzodioxolyl group Chemical group O1OC(C2=C1C=CC=C2)* 0.000 description 1
- 125000000499 benzofuranyl group Chemical group O1C(=CC2=C1C=CC=C2)* 0.000 description 1
- 125000004601 benzofurazanyl group Chemical group N1=C2C(=NO1)C(=CC=C2)* 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 125000005874 benzothiadiazolyl group Chemical group 0.000 description 1
- 125000001164 benzothiazolyl group Chemical group S1C(=NC2=C1C=CC=C2)* 0.000 description 1
- 125000003354 benzotriazolyl group Chemical group N1N=NC2=C1C=CC=C2* 0.000 description 1
- 125000004541 benzoxazolyl group Chemical group O1C(=NC2=C1C=CC=C2)* 0.000 description 1
- SNIABFMMCKVXSY-UHFFFAOYSA-N benzoylazanium;chloride Chemical compound Cl.NC(=O)C1=CC=CC=C1 SNIABFMMCKVXSY-UHFFFAOYSA-N 0.000 description 1
- YDURGSXAWQYHHH-UHFFFAOYSA-N benzyl 4-amino-3-phenylmethoxybenzoate;hydrochloride Chemical compound Cl.NC1=CC=C(C(=O)OCC=2C=CC=CC=2)C=C1OCC1=CC=CC=C1 YDURGSXAWQYHHH-UHFFFAOYSA-N 0.000 description 1
- SLLAEBVVJMSAJZ-UHFFFAOYSA-N benzyl 4-nitro-3-phenylmethoxybenzoate Chemical compound [O-][N+](=O)C1=CC=C(C(=O)OCC=2C=CC=CC=2)C=C1OCC1=CC=CC=C1 SLLAEBVVJMSAJZ-UHFFFAOYSA-N 0.000 description 1
- SIPUZPBQZHNSDW-UHFFFAOYSA-N bis(2-methylpropyl)aluminum Chemical compound CC(C)C[Al]CC(C)C SIPUZPBQZHNSDW-UHFFFAOYSA-N 0.000 description 1
- UORVGPXVDQYIDP-BJUDXGSMSA-N borane Chemical compound [10BH3] UORVGPXVDQYIDP-BJUDXGSMSA-N 0.000 description 1
- 229910000085 borane Inorganic materials 0.000 description 1
- MOOAHMCRPCTRLV-UHFFFAOYSA-N boron sodium Chemical compound [B].[Na] MOOAHMCRPCTRLV-UHFFFAOYSA-N 0.000 description 1
- NNTOJPXOCKCMKR-UHFFFAOYSA-N boron;pyridine Chemical class [B].C1=CC=NC=C1 NNTOJPXOCKCMKR-UHFFFAOYSA-N 0.000 description 1
- FLLNLJJKHKZKMB-UHFFFAOYSA-N boron;tetramethylazanium Chemical compound [B].C[N+](C)(C)C FLLNLJJKHKZKMB-UHFFFAOYSA-N 0.000 description 1
- 230000031709 bromination Effects 0.000 description 1
- 238000005893 bromination reaction Methods 0.000 description 1
- OTJZCIYGRUNXTP-UHFFFAOYSA-N but-3-yn-1-ol Chemical compound OCCC#C OTJZCIYGRUNXTP-UHFFFAOYSA-N 0.000 description 1
- 125000004369 butenyl group Chemical group C(=CCC)* 0.000 description 1
- 125000004744 butyloxycarbonyl group Chemical group 0.000 description 1
- 159000000007 calcium salts Chemical class 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 150000001768 cations Chemical class 0.000 description 1
- 239000003610 charcoal Substances 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 210000004978 chinese hamster ovary cell Anatomy 0.000 description 1
- QQVDYSUDFZZPSU-UHFFFAOYSA-M chloromethylidene(dimethyl)azanium;chloride Chemical compound [Cl-].C[N+](C)=CCl QQVDYSUDFZZPSU-UHFFFAOYSA-M 0.000 description 1
- KRVSOGSZCMJSLX-UHFFFAOYSA-L chromic acid Substances O[Cr](O)(=O)=O KRVSOGSZCMJSLX-UHFFFAOYSA-L 0.000 description 1
- 108010086192 chymostatin Proteins 0.000 description 1
- ONCCWDRMOZMNSM-FBCQKBJTSA-N compound Z Chemical compound N1=C2C(=O)NC(N)=NC2=NC=C1C(=O)[C@H]1OP(O)(=O)OC[C@H]1O ONCCWDRMOZMNSM-FBCQKBJTSA-N 0.000 description 1
- 125000002592 cumenyl group Chemical group C1(=C(C=CC=C1)*)C(C)C 0.000 description 1
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 description 1
- 229960002887 deanol Drugs 0.000 description 1
- WLXALCKAKGDNAT-UHFFFAOYSA-N diazoethane Chemical compound CC=[N+]=[N-] WLXALCKAKGDNAT-UHFFFAOYSA-N 0.000 description 1
- YNHIGQDRGKUECZ-UHFFFAOYSA-N dichloropalladium;triphenylphosphanium Chemical compound Cl[Pd]Cl.C1=CC=CC=C1[PH+](C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1[PH+](C=1C=CC=CC=1)C1=CC=CC=C1 YNHIGQDRGKUECZ-UHFFFAOYSA-N 0.000 description 1
- FAMRKDQNMBBFBR-BQYQJAHWSA-N diethyl azodicarboxylate Substances CCOC(=O)\N=N\C(=O)OCC FAMRKDQNMBBFBR-BQYQJAHWSA-N 0.000 description 1
- 125000004177 diethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- HPNMFZURTQLUMO-UHFFFAOYSA-N diethylamine Chemical compound CCNCC HPNMFZURTQLUMO-UHFFFAOYSA-N 0.000 description 1
- 125000001664 diethylamino group Chemical group [H]C([H])([H])C([H])([H])N(*)C([H])([H])C([H])([H])[H] 0.000 description 1
- 229940043279 diisopropylamine Drugs 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 125000006263 dimethyl aminosulfonyl group Chemical group [H]C([H])([H])N(C([H])([H])[H])S(*)(=O)=O 0.000 description 1
- XHFGWHUWQXTGAT-UHFFFAOYSA-N dimethylamine hydrochloride Natural products CNC(C)C XHFGWHUWQXTGAT-UHFFFAOYSA-N 0.000 description 1
- IUNMPGNGSSIWFP-UHFFFAOYSA-N dimethylaminopropylamine Chemical compound CN(C)CCCN IUNMPGNGSSIWFP-UHFFFAOYSA-N 0.000 description 1
- IQDGSYLLQPDQDV-UHFFFAOYSA-N dimethylazanium;chloride Chemical compound Cl.CNC IQDGSYLLQPDQDV-UHFFFAOYSA-N 0.000 description 1
- HCUYBXPSSCRKRF-UHFFFAOYSA-N diphosgene Chemical compound ClC(=O)OC(Cl)(Cl)Cl HCUYBXPSSCRKRF-UHFFFAOYSA-N 0.000 description 1
- WEHWNAOGRSTTBQ-UHFFFAOYSA-N dipropylamine Chemical compound CCCNCCC WEHWNAOGRSTTBQ-UHFFFAOYSA-N 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 239000008298 dragée Substances 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 230000032050 esterification Effects 0.000 description 1
- 238000005886 esterification reaction Methods 0.000 description 1
- IDGUHHHQCWSQLU-UHFFFAOYSA-N ethanol;hydrate Chemical compound O.CCO IDGUHHHQCWSQLU-UHFFFAOYSA-N 0.000 description 1
- 125000005678 ethenylene group Chemical group [H]C([*:1])=C([H])[*:2] 0.000 description 1
- 125000003754 ethoxycarbonyl group Chemical group C(=O)(OCC)* 0.000 description 1
- AGQNUQGDMJENTL-FNORWQNLSA-N ethyl (e)-6-(2-amino-5-methylphenoxy)hex-2-enoate Chemical compound CCOC(=O)\C=C\CCCOC1=CC(C)=CC=C1N AGQNUQGDMJENTL-FNORWQNLSA-N 0.000 description 1
- WCRFLFCBKNTKHU-FNORWQNLSA-N ethyl (e)-6-(5-methyl-2-nitrophenoxy)hex-2-enoate Chemical compound CCOC(=O)\C=C\CCCOC1=CC(C)=CC=C1[N+]([O-])=O WCRFLFCBKNTKHU-FNORWQNLSA-N 0.000 description 1
- NLZMNYKBTQKTTO-UHFFFAOYSA-N ethyl 2-[2-amino-3-[cyclohexyl(methyl)carbamoyl]phenoxy]acetate Chemical compound NC1=C(C(=O)N(C2CCCCC2)C)C=CC=C1OCC(=O)OCC NLZMNYKBTQKTTO-UHFFFAOYSA-N 0.000 description 1
- CONXHYLUJULINW-UHFFFAOYSA-N ethyl 2-[3-(2-nitrophenoxy)propoxy]acetate Chemical compound CCOC(=O)COCCCOC1=CC=CC=C1[N+]([O-])=O CONXHYLUJULINW-UHFFFAOYSA-N 0.000 description 1
- TYWPNCCRKURVOH-UHFFFAOYSA-N ethyl 4-(5-methyl-2-nitrophenoxy)butanoate Chemical compound CCOC(=O)CCCOC1=CC(C)=CC=C1[N+]([O-])=O TYWPNCCRKURVOH-UHFFFAOYSA-N 0.000 description 1
- OQKYBHKTLASXIY-UHFFFAOYSA-N ethyl 6-(5-methyl-2-nitrophenoxy)hexanoate Chemical compound CCOC(=O)CCCCCOC1=CC(C)=CC=C1[N+]([O-])=O OQKYBHKTLASXIY-UHFFFAOYSA-N 0.000 description 1
- UOHCATQKZBLRKF-UHFFFAOYSA-N ethyl 6-[5-methyl-2-[methyl-[4-[(2-nitrobenzoyl)amino]benzoyl]amino]phenoxy]hexanoate Chemical compound CCOC(=O)CCCCCOC1=CC(C)=CC=C1N(C)C(=O)C(C=C1)=CC=C1NC(=O)C1=CC=CC=C1[N+]([O-])=O UOHCATQKZBLRKF-UHFFFAOYSA-N 0.000 description 1
- MVEAAGBEUOMFRX-UHFFFAOYSA-N ethyl acetate;hydrochloride Chemical compound Cl.CCOC(C)=O MVEAAGBEUOMFRX-UHFFFAOYSA-N 0.000 description 1
- 125000006534 ethyl amino methyl group Chemical group [H]N(C([H])([H])*)C([H])([H])C([H])([H])[H] 0.000 description 1
- RIFGWPKJUGCATF-UHFFFAOYSA-N ethyl chloroformate Chemical compound CCOC(Cl)=O RIFGWPKJUGCATF-UHFFFAOYSA-N 0.000 description 1
- FAMRKDQNMBBFBR-UHFFFAOYSA-N ethyl n-ethoxycarbonyliminocarbamate Chemical compound CCOC(=O)N=NC(=O)OCC FAMRKDQNMBBFBR-UHFFFAOYSA-N 0.000 description 1
- 125000006125 ethylsulfonyl group Chemical group 0.000 description 1
- WMYNMYVRWWCRPS-UHFFFAOYSA-N ethynoxyethane Chemical group CCOC#C WMYNMYVRWWCRPS-UHFFFAOYSA-N 0.000 description 1
- 125000002534 ethynyl group Chemical group [H]C#C* 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 125000001153 fluoro group Chemical group F* 0.000 description 1
- 239000008098 formaldehyde solution Substances 0.000 description 1
- AWJWCTOOIBYHON-UHFFFAOYSA-N furo[3,4-b]pyrazine-5,7-dione Chemical compound C1=CN=C2C(=O)OC(=O)C2=N1 AWJWCTOOIBYHON-UHFFFAOYSA-N 0.000 description 1
- 125000002541 furyl group Chemical group 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 125000005843 halogen group Chemical group 0.000 description 1
- 125000005842 heteroatom Chemical group 0.000 description 1
- 125000003104 hexanoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000003707 hexyloxy group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])O* 0.000 description 1
- 125000005935 hexyloxycarbonyl group Chemical group 0.000 description 1
- IKDUDTNKRLTJSI-UHFFFAOYSA-N hydrazine monohydrate Substances O.NN IKDUDTNKRLTJSI-UHFFFAOYSA-N 0.000 description 1
- FLTNAARZMRHWHG-UHFFFAOYSA-N hydrobromide dihydrochloride Chemical compound Cl.Cl.Br FLTNAARZMRHWHG-UHFFFAOYSA-N 0.000 description 1
- BICAGYDGRXJYGD-UHFFFAOYSA-N hydrobromide;hydrochloride Chemical compound Cl.Br BICAGYDGRXJYGD-UHFFFAOYSA-N 0.000 description 1
- 229910000042 hydrogen bromide Inorganic materials 0.000 description 1
- LELOWRISYMNNSU-UHFFFAOYSA-N hydrogen cyanide Chemical compound N#C LELOWRISYMNNSU-UHFFFAOYSA-N 0.000 description 1
- 229910000040 hydrogen fluoride Inorganic materials 0.000 description 1
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 description 1
- 229940071870 hydroiodic acid Drugs 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 description 1
- NPZTUJOABDZTLV-UHFFFAOYSA-N hydroxybenzotriazole Substances O=C1C=CC=C2NNN=C12 NPZTUJOABDZTLV-UHFFFAOYSA-N 0.000 description 1
- 150000002460 imidazoles Chemical class 0.000 description 1
- 125000002632 imidazolidinyl group Chemical group 0.000 description 1
- 125000002883 imidazolyl group Chemical group 0.000 description 1
- 125000005945 imidazopyridyl group Chemical group 0.000 description 1
- 125000003453 indazolyl group Chemical group N1N=C(C2=C1C=CC=C2)* 0.000 description 1
- 125000003406 indolizinyl group Chemical group C=1(C=CN2C=CC=CC12)* 0.000 description 1
- 125000001041 indolyl group Chemical group 0.000 description 1
- 229910003480 inorganic solid Inorganic materials 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- 125000000904 isoindolyl group Chemical group C=1(NC=C2C=CC=CC12)* 0.000 description 1
- 125000000555 isopropenyl group Chemical group [H]\C([H])=C(\*)C([H])([H])[H] 0.000 description 1
- JJWLVOIRVHMVIS-UHFFFAOYSA-N isopropylamine Chemical compound CC(C)N JJWLVOIRVHMVIS-UHFFFAOYSA-N 0.000 description 1
- 125000005956 isoquinolyl group Chemical group 0.000 description 1
- 150000002542 isoureas Chemical class 0.000 description 1
- GWYFCOCPABKNJV-UHFFFAOYSA-N isovaleric acid Chemical compound CC(C)CC(O)=O GWYFCOCPABKNJV-UHFFFAOYSA-N 0.000 description 1
- 125000000842 isoxazolyl group Chemical group 0.000 description 1
- GDBQQVLCIARPGH-ULQDDVLXSA-N leupeptin Chemical compound CC(C)C[C@H](NC(C)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C=O)CCCN=C(N)N GDBQQVLCIARPGH-ULQDDVLXSA-N 0.000 description 1
- 108010052968 leupeptin Proteins 0.000 description 1
- YNESATAKKCNGOF-UHFFFAOYSA-N lithium bis(trimethylsilyl)amide Chemical compound [Li+].C[Si](C)(C)[N-][Si](C)(C)C YNESATAKKCNGOF-UHFFFAOYSA-N 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 159000000003 magnesium salts Chemical class 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 238000000968 medical method and process Methods 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 229910052987 metal hydride Inorganic materials 0.000 description 1
- CEAJFNBWKBTRQE-UHFFFAOYSA-N methanamine;methanol Chemical compound NC.OC CEAJFNBWKBTRQE-UHFFFAOYSA-N 0.000 description 1
- 229940098779 methanesulfonic acid Drugs 0.000 description 1
- QARBMVPHQWIHKH-UHFFFAOYSA-N methanesulfonyl chloride Chemical compound CS(Cl)(=O)=O QARBMVPHQWIHKH-UHFFFAOYSA-N 0.000 description 1
- WSFSSNUMVMOOMR-NJFSPNSNSA-N methanone Chemical compound O=[14CH2] WSFSSNUMVMOOMR-NJFSPNSNSA-N 0.000 description 1
- UZKWTJUDCOPSNM-UHFFFAOYSA-N methoxybenzene Substances CCCCOC=C UZKWTJUDCOPSNM-UHFFFAOYSA-N 0.000 description 1
- 125000001160 methoxycarbonyl group Chemical group [H]C([H])([H])OC(*)=O 0.000 description 1
- IZAHDUZMMYWCDJ-UHFFFAOYSA-N methyl 3-methoxy-4-[methyl-(2-phenylmethoxybenzoyl)amino]benzoate Chemical compound COC1=CC(C(=O)OC)=CC=C1N(C)C(=O)C1=CC=CC=C1OCC1=CC=CC=C1 IZAHDUZMMYWCDJ-UHFFFAOYSA-N 0.000 description 1
- CPXCDEMFNPKOEF-UHFFFAOYSA-N methyl 3-methylbenzoate Chemical compound COC(=O)C1=CC=CC(C)=C1 CPXCDEMFNPKOEF-UHFFFAOYSA-N 0.000 description 1
- UXSNXOMMJXTFEG-UHFFFAOYSA-N methyl 4-(bromomethyl)-3-methoxybenzoate Chemical compound COC(=O)C1=CC=C(CBr)C(OC)=C1 UXSNXOMMJXTFEG-UHFFFAOYSA-N 0.000 description 1
- VZQWYFJTANVASL-UHFFFAOYSA-N methyl 4-[(2-amino-5-methylphenoxy)methyl]benzoate Chemical compound C1=CC(C(=O)OC)=CC=C1COC1=CC(C)=CC=C1N VZQWYFJTANVASL-UHFFFAOYSA-N 0.000 description 1
- VSPNFPGBMOPSKE-UHFFFAOYSA-N methyl 4-[[5-methyl-2-(methylamino)phenoxy]methyl]benzoate Chemical compound CNC1=CC=C(C)C=C1OCC1=CC=C(C(=O)OC)C=C1 VSPNFPGBMOPSKE-UHFFFAOYSA-N 0.000 description 1
- ROZWUNOYMSUTKS-UHFFFAOYSA-N methyl 5-nitrothiophene-2-carboxylate Chemical compound COC(=O)C1=CC=C([N+]([O-])=O)S1 ROZWUNOYMSUTKS-UHFFFAOYSA-N 0.000 description 1
- FCYIJBKJTRHHGQ-UHFFFAOYSA-N methyl 6-[[2-[(2-amino-3-methoxybenzoyl)-methylamino]-5-methylphenoxy]methyl]pyridine-3-carboxylate Chemical compound NC1=C(C(=O)N(C)C2=C(C=C(C=C2)C)OCC2=CC=C(C=N2)C(=O)OC)C=CC=C1OC FCYIJBKJTRHHGQ-UHFFFAOYSA-N 0.000 description 1
- 229940095102 methyl benzoate Drugs 0.000 description 1
- 230000011987 methylation Effects 0.000 description 1
- 238000007069 methylation reaction Methods 0.000 description 1
- 125000000325 methylidene group Chemical group [H]C([H])=* 0.000 description 1
- 125000004170 methylsulfonyl group Chemical group [H]C([H])([H])S(*)(=O)=O 0.000 description 1
- 125000006518 morpholino carbonyl group Chemical group [H]C1([H])OC([H])([H])C([H])([H])N(C(*)=O)C1([H])[H] 0.000 description 1
- MKDYQLJYEBWUIG-UHFFFAOYSA-N n',n'-diethyl-n-methylethane-1,2-diamine Chemical compound CCN(CC)CCNC MKDYQLJYEBWUIG-UHFFFAOYSA-N 0.000 description 1
- DILRJUIACXKSQE-UHFFFAOYSA-N n',n'-dimethylethane-1,2-diamine Chemical compound CN(C)CCN DILRJUIACXKSQE-UHFFFAOYSA-N 0.000 description 1
- HVOYZOQVDYHUPF-UHFFFAOYSA-N n,n',n'-trimethylethane-1,2-diamine Chemical compound CNCCN(C)C HVOYZOQVDYHUPF-UHFFFAOYSA-N 0.000 description 1
- UHAAFJWANJYDIS-UHFFFAOYSA-N n,n'-diethylmethanediimine Chemical compound CCN=C=NCC UHAAFJWANJYDIS-UHFFFAOYSA-N 0.000 description 1
- VMESOKCXSYNAKD-UHFFFAOYSA-N n,n-dimethylhydroxylamine Chemical compound CN(C)O VMESOKCXSYNAKD-UHFFFAOYSA-N 0.000 description 1
- ZZYFYQZALUBVRO-UHFFFAOYSA-N n-[2-[6-(4-methylpiperazin-1-yl)-6-oxohexoxy]phenyl]benzamide Chemical compound C1CN(C)CCN1C(=O)CCCCCOC1=CC=CC=C1NC(=O)C1=CC=CC=C1 ZZYFYQZALUBVRO-UHFFFAOYSA-N 0.000 description 1
- ZMPDQKFNGWYAIF-UHFFFAOYSA-N n-[2-[6-[4-(dimethylamino)piperidin-1-yl]-6-oxohexoxy]-4-methylphenyl]-4-[(2-hydroxybenzoyl)amino]-3-methoxy-n-methylbenzamide Chemical compound COC1=CC(C(=O)N(C)C=2C(=CC(C)=CC=2)OCCCCCC(=O)N2CCC(CC2)N(C)C)=CC=C1NC(=O)C1=CC=CC=C1O ZMPDQKFNGWYAIF-UHFFFAOYSA-N 0.000 description 1
- RFTPFAZGAZTVJJ-UHFFFAOYSA-N n-[4-[2-[[4-[[2-(3-aminopropoxy)benzoyl]amino]-3-methoxybenzoyl]-methylamino]-5-methylphenoxy]butyl]-4-(dimethylamino)piperidine-1-carboxamide;dihydrochloride Chemical compound Cl.Cl.COC1=CC(C(=O)N(C)C=2C(=CC(C)=CC=2)OCCCCNC(=O)N2CCC(CC2)N(C)C)=CC=C1NC(=O)C1=CC=CC=C1OCCCN RFTPFAZGAZTVJJ-UHFFFAOYSA-N 0.000 description 1
- YBBXVHCCAXPBBE-UHFFFAOYSA-N n-[4-methyl-2-[6-(4-methylpiperazin-1-yl)-6-oxohexoxy]phenyl]benzamide Chemical compound C1CN(C)CCN1C(=O)CCCCCOC1=CC(C)=CC=C1NC(=O)C1=CC=CC=C1 YBBXVHCCAXPBBE-UHFFFAOYSA-N 0.000 description 1
- RWIVICVCHVMHMU-UHFFFAOYSA-N n-aminoethylmorpholine Chemical compound NCCN1CCOCC1 RWIVICVCHVMHMU-UHFFFAOYSA-N 0.000 description 1
- JVHPKYBRJQNPAT-UHFFFAOYSA-N n-cyclohexyl-2,2-diphenylethenimine Chemical compound C1CCCCC1N=C=C(C=1C=CC=CC=1)C1=CC=CC=C1 JVHPKYBRJQNPAT-UHFFFAOYSA-N 0.000 description 1
- PXSXRABJBXYMFT-UHFFFAOYSA-N n-hexylhexan-1-amine Chemical compound CCCCCCNCCCCCC PXSXRABJBXYMFT-UHFFFAOYSA-N 0.000 description 1
- JACMPVXHEARCBO-UHFFFAOYSA-N n-pentylpentan-1-amine Chemical compound CCCCCNCCCCC JACMPVXHEARCBO-UHFFFAOYSA-N 0.000 description 1
- 125000001038 naphthoyl group Chemical group C1(=CC=CC2=CC=CC=C12)C(=O)* 0.000 description 1
- 125000001624 naphthyl group Chemical group 0.000 description 1
- LAIZPRYFQUWUBN-UHFFFAOYSA-L nickel chloride hexahydrate Chemical compound O.O.O.O.O.O.[Cl-].[Cl-].[Ni+2] LAIZPRYFQUWUBN-UHFFFAOYSA-L 0.000 description 1
- VLZLOWPYUQHHCG-UHFFFAOYSA-N nitromethylbenzene Chemical compound [O-][N+](=O)CC1=CC=CC=C1 VLZLOWPYUQHHCG-UHFFFAOYSA-N 0.000 description 1
- DMAHAPVVMOIVNW-UHFFFAOYSA-N o-methyl 2-(3-hydroxypropyl)benzenecarbothioate Chemical compound COC(=S)C1=CC=CC=C1CCCO DMAHAPVVMOIVNW-UHFFFAOYSA-N 0.000 description 1
- GRMUZCMKBXHMRH-UHFFFAOYSA-N o-methyl 2-[3-[(4-methoxyphenyl)methoxy]propyl]benzenecarbothioate Chemical compound COC(=S)C1=CC=CC=C1CCCOCC1=CC=C(OC)C=C1 GRMUZCMKBXHMRH-UHFFFAOYSA-N 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 210000001672 ovary Anatomy 0.000 description 1
- 125000001715 oxadiazolyl group Chemical group 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 239000001301 oxygen Chemical group 0.000 description 1
- 125000003232 p-nitrobenzoyl group Chemical group [N+](=O)([O-])C1=CC=C(C(=O)*)C=C1 0.000 description 1
- 125000006503 p-nitrobenzyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1[N+]([O-])=O)C([H])([H])* 0.000 description 1
- 125000001037 p-tolyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1*)C([H])([H])[H] 0.000 description 1
- MUJIDPITZJWBSW-UHFFFAOYSA-N palladium(2+) Chemical compound [Pd+2] MUJIDPITZJWBSW-UHFFFAOYSA-N 0.000 description 1
- 125000001147 pentyl group Chemical group C(CCCC)* 0.000 description 1
- 229940100684 pentylamine Drugs 0.000 description 1
- KHIWWQKSHDUIBK-UHFFFAOYSA-N periodic acid Chemical compound OI(=O)(=O)=O KHIWWQKSHDUIBK-UHFFFAOYSA-N 0.000 description 1
- 150000004965 peroxy acids Chemical class 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 125000000951 phenoxy group Chemical group [H]C1=C([H])C([H])=C(O*)C([H])=C1[H] 0.000 description 1
- 125000006678 phenoxycarbonyl group Chemical group 0.000 description 1
- GQKFMILWGWQUTP-UHFFFAOYSA-N phenyl N-[4-[2-[(2-amino-3-methoxybenzoyl)-methylamino]-5-methylphenoxy]butyl]carbamate Chemical compound NC1=C(C(=O)N(C)C2=C(C=C(C=C2)C)OCCCCNC(=O)OC2=CC=CC=C2)C=CC=C1OC GQKFMILWGWQUTP-UHFFFAOYSA-N 0.000 description 1
- QIIPQYDSKRYMFG-UHFFFAOYSA-M phenyl carbonate Chemical compound [O-]C(=O)OC1=CC=CC=C1 QIIPQYDSKRYMFG-UHFFFAOYSA-M 0.000 description 1
- AHWALFGBDFAJAI-UHFFFAOYSA-N phenyl carbonochloridate Chemical compound ClC(=O)OC1=CC=CC=C1 AHWALFGBDFAJAI-UHFFFAOYSA-N 0.000 description 1
- DGTNSSLYPYDJGL-UHFFFAOYSA-N phenyl isocyanate Chemical compound O=C=NC1=CC=CC=C1 DGTNSSLYPYDJGL-UHFFFAOYSA-N 0.000 description 1
- 125000000843 phenylene group Chemical group C1(=C(C=CC=C1)*)* 0.000 description 1
- 125000003170 phenylsulfonyl group Chemical group C1(=CC=CC=C1)S(=O)(=O)* 0.000 description 1
- PMOIAJVKYNVHQE-UHFFFAOYSA-N phosphanium;bromide Chemical compound [PH4+].[Br-] PMOIAJVKYNVHQE-UHFFFAOYSA-N 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- OJMIONKXNSYLSR-UHFFFAOYSA-N phosphorous acid Chemical compound OP(O)O OJMIONKXNSYLSR-UHFFFAOYSA-N 0.000 description 1
- 150000003018 phosphorus compounds Chemical class 0.000 description 1
- XUWHAWMETYGRKB-UHFFFAOYSA-N piperidin-2-one Chemical compound O=C1CCCCN1 XUWHAWMETYGRKB-UHFFFAOYSA-N 0.000 description 1
- IUGYQRQAERSCNH-UHFFFAOYSA-N pivalic acid Chemical compound CC(C)(C)C(O)=O IUGYQRQAERSCNH-UHFFFAOYSA-N 0.000 description 1
- 125000003367 polycyclic group Chemical group 0.000 description 1
- 239000001205 polyphosphate Substances 0.000 description 1
- 235000011176 polyphosphates Nutrition 0.000 description 1
- 229920000137 polyphosphoric acid Polymers 0.000 description 1
- 239000012286 potassium permanganate Substances 0.000 description 1
- 159000000001 potassium salts Chemical class 0.000 description 1
- LPNYRYFBWFDTMA-UHFFFAOYSA-N potassium tert-butoxide Chemical compound [K+].CC(C)(C)[O-] LPNYRYFBWFDTMA-UHFFFAOYSA-N 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 238000012746 preparative thin layer chromatography Methods 0.000 description 1
- IVRIRQXJSNCSPQ-UHFFFAOYSA-N propan-2-yl carbonochloridate Chemical compound CC(C)OC(Cl)=O IVRIRQXJSNCSPQ-UHFFFAOYSA-N 0.000 description 1
- 125000006410 propenylene group Chemical group 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000004742 propyloxycarbonyl group Chemical group 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 125000004309 pyranyl group Chemical group O1C(C=CC=C1)* 0.000 description 1
- 125000003373 pyrazinyl group Chemical group 0.000 description 1
- 125000003226 pyrazolyl group Chemical group 0.000 description 1
- 125000002098 pyridazinyl group Chemical group 0.000 description 1
- GZRKXKUVVPSREJ-UHFFFAOYSA-N pyridinylpiperazine Chemical compound C1CNCCN1C1=CC=CC=N1 GZRKXKUVVPSREJ-UHFFFAOYSA-N 0.000 description 1
- 125000001422 pyrrolinyl group Chemical group 0.000 description 1
- 125000005493 quinolyl group Chemical group 0.000 description 1
- 239000002516 radical scavenger Substances 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 238000001226 reprecipitation Methods 0.000 description 1
- XGVXKJKTISMIOW-ZDUSSCGKSA-N simurosertib Chemical compound N1N=CC(C=2SC=3C(=O)NC(=NC=3C=2)[C@H]2N3CCC(CC3)C2)=C1C XGVXKJKTISMIOW-ZDUSSCGKSA-N 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 125000005415 substituted alkoxy group Chemical group 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000007940 sugar coated tablet Substances 0.000 description 1
- 239000011593 sulfur Chemical group 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 239000000829 suppository Substances 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 229940095064 tartrate Drugs 0.000 description 1
- DYHSDKLCOJIUFX-UHFFFAOYSA-N tert-butoxycarbonyl anhydride Chemical compound CC(C)(C)OC(=O)OC(=O)OC(C)(C)C DYHSDKLCOJIUFX-UHFFFAOYSA-N 0.000 description 1
- PWQLFIKTGRINFF-UHFFFAOYSA-N tert-butyl 4-hydroxypiperidine-1-carboxylate Chemical compound CC(C)(C)OC(=O)N1CCC(O)CC1 PWQLFIKTGRINFF-UHFFFAOYSA-N 0.000 description 1
- RUPAXCPQAAOIPB-UHFFFAOYSA-N tert-butyl formate Chemical group CC(C)(C)OC=O RUPAXCPQAAOIPB-UHFFFAOYSA-N 0.000 description 1
- UQLYDIDMLDTUDL-UHFFFAOYSA-N tert-butyl n-(2-hydroxyphenyl)carbamate Chemical compound CC(C)(C)OC(=O)NC1=CC=CC=C1O UQLYDIDMLDTUDL-UHFFFAOYSA-N 0.000 description 1
- VZRXODLJQGXZHY-UHFFFAOYSA-N tert-butyl n-(2-phenylmethoxyphenyl)carbamate Chemical compound CC(C)(C)OC(=O)NC1=CC=CC=C1OCC1=CC=CC=C1 VZRXODLJQGXZHY-UHFFFAOYSA-N 0.000 description 1
- AWDAXKRUVMNAMS-UHFFFAOYSA-N tert-butyl n-[2-[6-[4-(dimethylamino)piperidin-1-yl]-6-oxohexoxy]-4-methylphenyl]carbamate Chemical compound C1CC(N(C)C)CCN1C(=O)CCCCCOC1=CC(C)=CC=C1NC(=O)OC(C)(C)C AWDAXKRUVMNAMS-UHFFFAOYSA-N 0.000 description 1
- GPTFDLIPWMESGI-UHFFFAOYSA-N tert-butyl n-[3-(2-hydroxyphenoxy)propyl]carbamate Chemical compound CC(C)(C)OC(=O)NCCCOC1=CC=CC=C1O GPTFDLIPWMESGI-UHFFFAOYSA-N 0.000 description 1
- QSWILKCLLGALQM-UHFFFAOYSA-N tert-butyl n-[3-(2-phenylmethoxyphenoxy)propyl]carbamate Chemical compound CC(C)(C)OC(=O)NCCCOC1=CC=CC=C1OCC1=CC=CC=C1 QSWILKCLLGALQM-UHFFFAOYSA-N 0.000 description 1
- ZDZNAEXUCKHKLL-UHFFFAOYSA-N tert-butyl n-[3-[2-[[2-methoxy-4-[methyl-[4-methyl-2-(6-oxohexoxy)phenyl]carbamoyl]phenyl]carbamoyl]phenoxy]propyl]carbamate Chemical compound COC1=CC(C(=O)N(C)C=2C(=CC(C)=CC=2)OCCCCCC=O)=CC=C1NC(=O)C1=CC=CC=C1OCCCNC(=O)OC(C)(C)C ZDZNAEXUCKHKLL-UHFFFAOYSA-N 0.000 description 1
- MJLVOOANVPMZFL-UHFFFAOYSA-N tert-butyl n-[3-[2-[[2-methoxy-4-[methyl-[4-methyl-2-[6-(4-methylpiperazin-1-yl)-6-oxohexoxy]phenyl]carbamoyl]phenyl]carbamoyl]phenoxy]propyl]carbamate Chemical compound COC1=CC(C(=O)N(C)C=2C(=CC(C)=CC=2)OCCCCCC(=O)N2CCN(C)CC2)=CC=C1NC(=O)C1=CC=CC=C1OCCCNC(=O)OC(C)(C)C MJLVOOANVPMZFL-UHFFFAOYSA-N 0.000 description 1
- XCMAGGPBIBUTLA-UHFFFAOYSA-N tert-butyl n-[3-[2-[[4-[(4-hydroxyphenyl)-methylcarbamoyl]-2-methoxyphenyl]carbamoyl]phenoxy]propyl]carbamate Chemical compound COC1=CC(C(=O)N(C)C=2C=CC(O)=CC=2)=CC=C1NC(=O)C1=CC=CC=C1OCCCNC(=O)OC(C)(C)C XCMAGGPBIBUTLA-UHFFFAOYSA-N 0.000 description 1
- UOJWKJSIXNSAMW-UHFFFAOYSA-N tert-butyl n-[3-[2-[[4-[[2-(4-aminobutoxy)-4-methylphenyl]-methylcarbamoyl]-2-methoxyphenyl]carbamoyl]phenoxy]propyl]carbamate Chemical compound COC1=CC(C(=O)N(C)C=2C(=CC(C)=CC=2)OCCCCN)=CC=C1NC(=O)C1=CC=CC=C1OCCCNC(=O)OC(C)(C)C UOJWKJSIXNSAMW-UHFFFAOYSA-N 0.000 description 1
- OSQYOZVVLAOMFE-UHFFFAOYSA-N tert-butyl n-[3-[2-[[4-[[2-(6-hydroxyhexoxy)-4-methylphenyl]-methylcarbamoyl]-2-methoxyphenyl]carbamoyl]phenoxy]propyl]carbamate Chemical compound COC1=CC(C(=O)N(C)C=2C(=CC(C)=CC=2)OCCCCCCO)=CC=C1NC(=O)C1=CC=CC=C1OCCCNC(=O)OC(C)(C)C OSQYOZVVLAOMFE-UHFFFAOYSA-N 0.000 description 1
- FMYZTNYUCMGHPW-UHFFFAOYSA-N tert-butyl n-[3-[2-[[4-[[2-[6-(4-hydroxypiperidin-1-yl)-6-oxohexoxy]-4-methylphenyl]-methylcarbamoyl]-2-methoxyphenyl]carbamoyl]phenoxy]propyl]carbamate Chemical compound COC1=CC(C(=O)N(C)C=2C(=CC(C)=CC=2)OCCCCCC(=O)N2CCC(O)CC2)=CC=C1NC(=O)C1=CC=CC=C1OCCCNC(=O)OC(C)(C)C FMYZTNYUCMGHPW-UHFFFAOYSA-N 0.000 description 1
- VBUWHAJDOUIJMV-UHFFFAOYSA-N tert-butyl n-propylcarbamate Chemical compound CCCNC(=O)OC(C)(C)C VBUWHAJDOUIJMV-UHFFFAOYSA-N 0.000 description 1
- 125000003718 tetrahydrofuranyl group Chemical group 0.000 description 1
- 150000003536 tetrazoles Chemical class 0.000 description 1
- 125000001113 thiadiazolyl group Chemical group 0.000 description 1
- 125000001984 thiazolidinyl group Chemical group 0.000 description 1
- BRNULMACUQOKMR-UHFFFAOYSA-N thiomorpholine Chemical compound C1CSCCN1 BRNULMACUQOKMR-UHFFFAOYSA-N 0.000 description 1
- NBOMNTLFRHMDEZ-UHFFFAOYSA-N thiosalicylic acid Chemical compound OC(=O)C1=CC=CC=C1S NBOMNTLFRHMDEZ-UHFFFAOYSA-N 0.000 description 1
- 229940103494 thiosalicylic acid Drugs 0.000 description 1
- 125000005425 toluyl group Chemical group 0.000 description 1
- 125000002088 tosyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1C([H])([H])[H])S(*)(=O)=O 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- 238000001890 transfection Methods 0.000 description 1
- 150000003852 triazoles Chemical class 0.000 description 1
- 125000001425 triazolyl group Chemical group 0.000 description 1
- RXJKFRMDXUJTEX-UHFFFAOYSA-N triethylphosphine Chemical compound CCP(CC)CC RXJKFRMDXUJTEX-UHFFFAOYSA-N 0.000 description 1
- UORVGPXVDQYIDP-UHFFFAOYSA-N trihydridoboron Substances B UORVGPXVDQYIDP-UHFFFAOYSA-N 0.000 description 1
- IIHPVYJPDKJYOU-UHFFFAOYSA-N triphenylcarbethoxymethylenephosphorane Chemical compound C=1C=CC=CC=1P(C=1C=CC=CC=1)(=CC(=O)OCC)C1=CC=CC=C1 IIHPVYJPDKJYOU-UHFFFAOYSA-N 0.000 description 1
- 125000002221 trityl group Chemical group [H]C1=C([H])C([H])=C([H])C([H])=C1C([*])(C1=C(C(=C(C(=C1[H])[H])[H])[H])[H])C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 1
- 125000003774 valeryl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 230000000304 vasodilatating effect Effects 0.000 description 1
- 229940124549 vasodilator Drugs 0.000 description 1
- 239000003071 vasodilator agent Substances 0.000 description 1
- 229920001567 vinyl ester resin Polymers 0.000 description 1
- 238000009736 wetting Methods 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/44—Iso-indoles; Hydrogenated iso-indoles
- C07D209/48—Iso-indoles; Hydrogenated iso-indoles with oxygen atoms in positions 1 and 3, e.g. phthalimide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/42—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
- C07C237/28—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton
- C07C237/42—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton having nitrogen atoms of amino groups bound to the carbon skeleton of the acid part, further acylated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
- C07C237/28—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton
- C07C237/44—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton having carbon atoms of carboxamide groups, amino groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C243/00—Compounds containing chains of nitrogen atoms singly-bound to each other, e.g. hydrazines, triazanes
- C07C243/24—Hydrazines having nitrogen atoms of hydrazine groups acylated by carboxylic acids
- C07C243/26—Hydrazines having nitrogen atoms of hydrazine groups acylated by carboxylic acids with acylating carboxyl groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C243/28—Hydrazines having nitrogen atoms of hydrazine groups acylated by carboxylic acids with acylating carboxyl groups bound to hydrogen atoms or to acyclic carbon atoms to hydrogen atoms or to carbon atoms of a saturated carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
- C07C255/49—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C255/54—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and etherified hydroxy groups bound to the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
- C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C271/16—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by singly-bound oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
- C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C271/22—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by carboxyl groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/40—Esters of carbamic acids having oxygen atoms of carbamate groups bound to carbon atoms of six-membered aromatic rings
- C07C271/42—Esters of carbamic acids having oxygen atoms of carbamate groups bound to carbon atoms of six-membered aromatic rings with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C271/48—Esters of carbamic acids having oxygen atoms of carbamate groups bound to carbon atoms of six-membered aromatic rings with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by singly-bound oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
- C07C279/04—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton
- C07C279/08—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton being further substituted by singly-bound oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
- C07C279/20—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups containing any of the groups, X being a hetero atom, Y being any atom, e.g. acylguanidines
- C07C279/24—Y being a hetero atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/40—Oxygen atoms
- C07D211/44—Oxygen atoms attached in position 4
- C07D211/46—Oxygen atoms attached in position 4 having a hydrogen atom as the second substituent in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/56—Nitrogen atoms
- C07D211/58—Nitrogen atoms attached in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D211/72—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D211/74—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
- C07D213/30—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/79—Acids; Esters
- C07D213/80—Acids; Esters in position 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/26—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
- C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
- C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
- C07D295/182—Radicals derived from carboxylic acids
- C07D295/185—Radicals derived from carboxylic acids from aliphatic carboxylic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
- C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
- C07D295/182—Radicals derived from carboxylic acids
- C07D295/192—Radicals derived from carboxylic acids from aromatic carboxylic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
- C07D295/20—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof
- C07D295/205—Radicals derived from carbonic acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
- C07D295/20—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof
- C07D295/215—Radicals derived from nitrogen analogues of carbonic acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/22—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with hetero atoms directly attached to ring nitrogen atoms
- C07D295/26—Sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/22—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with hetero atoms directly attached to ring nitrogen atoms
- C07D295/28—Nitrogen atoms
- C07D295/32—Nitrogen atoms acylated with carboxylic or carbonic acids, or their nitrogen or sulfur analogues
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Cardiology (AREA)
- Obesity (AREA)
- Heart & Thoracic Surgery (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Urology & Nephrology (AREA)
- Reproductive Health (AREA)
- Gastroenterology & Hepatology (AREA)
- Otolaryngology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Plural Heterocyclic Compounds (AREA)
- Indole Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Pyrrole Compounds (AREA)
Abstract
Description
Claims (9)
- 【請求項1】式 〔式中、 R1はアリ−ル、シクロ低級アルキルまたは複素環基であり、それらの各々は 、ハロゲン;ヒドロキシ;ニトロ;アミノ;アシル;置換アシル;アシル低級ア ルキルスルフィニル;アシル低級アルキルスルホニル;アシルオキシ;低級アル キルアミノ低級アルキルカルバモイルオキシ;アリ−ル;シアノ;複素環基;ア シル、置換アシル、アリ−ルもしくはアシル置換アリ−ルで置換されていてもよ い低級アルケニル;アミノ、アシルアミノもしくは置換アシルアミノで置換され ていてもよい低級アルキニル;ハロゲン、アミノ、低級アルキルアミノ、アシル アミノ、置換アシルアミノ、ヒドロキシ、アシルオキシ、アシル低級アルカノイ ルオキシ、アシル、置換アシル、アシル低級アルコキシイミノ、アリ−ルもしく はアシル置換アリ−ルで置換されていてもよい低級アルキル;アシルもしくは置 換アシルで置換されていてもよい低級アルキルチオ;アリ−ル、置換アリ−ル、 ヒドロキシ、アシルオキシ、アミノ、低級アルキルアミノ、保護されたアミノ、 複素環基、アシル置換ピリジル、置換アシル置換ピリジル、ハロゲン、アシル低 級アルキルアミノ、N−保護されたアシル低級アルキルアミノ、N−アシル低級 アルキル−N−低級アルキルアミノ、アシル、置換アシル、アシルアミノ、置換 アシルアミノ、低級アルキルヒドラジノカルボニルアミノ、ヒドロキシイミノ、 アシル低級アルコキシイミノ、置換アシル低級アルコキシイミノ、アシル低級ア ルコキシ、グアニジノもしくはN−保護されたグアニジノで置換されていてもよ いアルコキシ;および、アシルもしくは置換アシルで置換されていてもよい低級 アルケニルオキシからなる群から選ばれた置換基で置換されていてもよく; R2は水素;ヒドロキシ、アリ−ルもしくはアシルで置換されていてもよい低 級アルキル;またはシクロ低級アルキルであり; R3は水素;ハロゲン;ヒドロキシ;アシルオキシ;置換アシルオキシ;ヒド ロキシもしくは低級アルコキシで置換されていてもよい低級アルキル;アリ−ル 、アミノ、保護されたアミノ、アシル、ヒドロキシ、シアノもしくは低級アルキ ルチオで置換されていてもよい低級アルコキシ;ニトロ;アミノ;アシル;置換 アシル;またはシクロ低級アルキルオキシであり; R4はヒドロキシ;ハロゲン;ニトロ;アミノ;保護されたアミノ;低級アル キルアミノ;アシルオキシ;アミノ低級アルキルアミノ;N−保護されたアミノ 低級アルキルアミノ;ヒドロキシ、アリ−ル、置換アリ−ル、アシル、置換アシ ル、アミノ、低級アルキルアミノ、アシルアミノ、置換アシルアミノ、保護され たアミノ、複素環基もしくはグアニジノで置換されていてもよい低級アルコキシ ;アシル、置換アシル、アミノ、低級アルキルアミノ、アシルアミノ、置換アシ ルアミノ、保護されたアミノ、複素環基、ヒドロキシ、低級アルキルスルホニル オキシ、アリ−ルスルホニルオキシ、アル低級アルコキシもしくは置換アル低級 アルコキシで置換されていてもよい低級アルキルチオ;アシル、置換アシル、ア ミノ、低級アルキルアミノ、アシルアミノ、置換アシルアミノ、保護されたアミ ノ、複素環基、ヒドロキシ、低級アルキルスルホニルオキシもしくはアリ−ルス ルホニルオキシで置換された低級アルキル;アシルで置換されていてもよい低級 アルケニル;ヒドロキシ、アミノ、保護されたアミノ、低級アルキルスルホニル オキシもしくはアリ−ルスルホニルオキシで置換されていてもよい低級アルキニ ル;アミノ低級アルキルスルホニル;N−保護されたアミノ低級アルキルスルホ ニル;低級アルキルアミノスルホニル;複素環スルホニル;アミノ低級アルキル スルフィニル;N−保護されたアミノ低級アルキルスルフィニル;ピペリジルオ キシ;またはN−保護されたピペリジルオキシであり; R5は水素、低級アルキル、低級アルコキシまたはハロゲンであり; Aは単結合、OまたはNHであり; Eは低級アルキレン、低級アルケニレン、−CO−、−SO2−または式 −G−J− 〔ここに、Gは低級アルキレンであり、JはOまたは−N(R6)−(ここに、 R6は水素またはN−保護基である)である〕の基であり; Xは−CH=CH−、−CH=N−またはSであり; YはCHまたはNである〕 の化合物およびその医薬として許容される塩。
- 【請求項2】R1が、アシルアミノもしくはアシルで置換されていてもよい低級 アルコキシで置換されていてもよいアリ−ルであり; R2が低級アルキルであり; R3が水素、低級アルキルまたは低級アルコキシであり; R4がヒドロキシまたは各々にヒドロキシ、アリ−ル、置換アリ−ル、アシル 、アミノ、低級アルキルアミノ、アシルアミノ、保護されたアミノもしくは複素 環基で置換されていてもよい低級アルコキシ、低級アルキルチオまたは低級アル キルであり; R5が水素、低級アルキル、低級アルコキシまたはハロゲンであり; AがNHであり; Eが−CO−であり; Xが−CH=CH−であり; YがCHである 請求項1の化合物。
- 【請求項3】R1が、各々にアシルで置換された低級アルコキシで置換されてい るフェニルまたはトリルであり; R3が低級アルコキシまたは低級アルキルであり; R4が、各々にアミノもしくはヒドロキシで置換されている低級アルコキシ、 低級アルキルチオまたは低級アルキルである 請求項2の化合物。
- 【請求項4】R1が、各々にN−低級アルキルピペラジニルカルボニルで置換さ れた低級アルコキシで置換されているフェニルまたはトリルであり; R3が低級アルコキシであり; R4がアミノで置換されている低級アルコキシであり; R5が水素である 請求項3の化合物。
- 【請求項5】式 〔式中、 R1はアリ−ル、シクロ低級アルキルまたは複素環基であり、それらの各々は 、ハロゲン;ヒドロキシ;ニトロ;アミノ;アシル;置換アシル;アシル低級ア ルキルスルフィニル;アシル低級アルキルスルホニル;アシルオキシ;低級アル キルアミノ低級アルキルカルバモイルオキシ;アリ−ル;シアノ;複素環基;ア シル、置換アシル、アリ−ルもしくはアシル置換アリ−ルで置換されていてもよ い低級アルケニル;アミノ、アシルアミノもしくは置換アシルアミノで置換され ていてもよい低級アルキニル;ハロゲン、アミノ、低級アルキルアミノ、アシル アミノ、置換アシルアミノ、ヒドロキシ、アシルオキシ、アシル低級アルカノイ ルオキシ、アシル、置換アシル、アシル低級アルコキシイミノ、アリ−ルもしく はアシル置換アリ−ルで置換されていてもよい低級アルキル;アシルもしくは置 換アシルで置換されていてもよい低級アルキルチオ;アリ−ル、置換アリ−ル、 ヒドロキシ、アシルオキシ、アミノ、低級アルキルアミノ、保護されたアミノ、 複素環基、アシル置換ピリジル、置換アシル置換ピリジル、ハロゲン、アシル低 級アルキルアミノ、N−保護されたアシル低級アルキルアミノ、N−アシル低級 アルキル−N−低級アルキルアミノ、アシル、置換アシル、アシルアミノ、置換 アシルアミノ、低級アルキルヒドラジノカルボニルアミノ、ヒドロキシイミノ、 アシル低級アルコキシイミノ、置換アシル低級アルコキシイミノ、アシル低級ア ルコキシ、グアニジノもしくはN−保護されたグアニジノで置換されていてもよ いアルコキシ;および、アシルもしくは置換アシルで置換されていてもよい 低級アルケニルオキシからなる群から選ばれた置換基で置換されていてもよく; R2は水素;ヒドロキシ、アリ−ルもしくはアシルで置換されていてもよい低 級アルキル;またはシクロ低級アルキルであり; R3は水素;ハロゲン;ヒドロキシ;アシルオキシ;置換アシルオキシ;ヒド ロキシもしくは低級アルコキシで置換されていてもよい低級アルキル;アリ−ル 、アミノ、保護されたアミノ、アシル、ヒドロキシ、シアノもしくは低級アルキ ルチオで置換されていてもよい低級アルコキシ;ニトロ;アミノ;アシル;置換 アシル;またはシクロ低級アルキルオキシであり; R4はヒドロキシ;ハロゲン;ニトロ;アミノ;保護されたアミノ;低級アル キルアミノ;アシルオキシ;アミノ低級アルキルアミノ;N−保護されたアミノ 低級アルキルアミノ;ヒドロキシ、アリ−ル、置換アリ−ル、アシル、置換アシ ル、アミノ、低級アルキルアミノ、アシルアミノ、置換アシルアミノ、保護され たアミノ、複素環基もしくはグアニジノで置換されていてもよい低級アルコキシ ;アシル、置換アシル、アミノ、低級アルキルアミノ、アシルアミノ、置換アシ ルアミノ、保護されたアミノ、複素環基、ヒドロキシ、低級アルキルスルホニル オキシ、アリ−ルスルホニルオキシ、アル低級アルコキシもしくは置換アル低級 アルコキシで置換されていてもよい低級アルキルチオ;アシル、置換アシル、ア ミノ、低級アルキルアミノ、アシルアミノ、置換アシルアミノ、保護されたアミ ノ、複素環基、ヒドロキシ、低級アルキルスルホニルオキシもしくはアリ−ルス ルホニルオキシで置換された低級アルキル;アシルで置換されていてもよい低級 アルケニル;ヒドロキシ、アミノ、保護されたアミノ、低級アルキルスルホニル オキシもしくはアリ−ルスルホニルオキシで置換されていてもよい低級アルキニ ル;アミノ低級アルキルスルホニル;N−保護されたアミノ低級アルキルスルホ ニル;低級アルキルアミノスルホニル;複素環スルホニル;アミノ低級アルキル スルフィニル;N−保護されたアミノ低級アルキルスルフィニル;ピペリジルオ キシ;またはN−保護されたピペリジルオキシであり; R5は水素、低級アルキル、低級アルコキシまたはハロゲンであり; Aは単結合、OまたはNHであり; Eは低級アルキレン、低級アルケニレン、−CO−、−SO2−または式 −G−J− 〔ここに、Gは低級アルキレンであり、JはOまたは−N(R6)−(ここに、 R6は水素またはN−保護基である)である〕の基であり; Xは−CH=CH−、−CH=N−またはSであり; YはCHまたはNである〕 の化合物またはその医薬として許容される塩の製造法であって、 1)式 の化合物またはその塩を式 の化合物またはそのカルボキシ基またはスルホ基における反応性誘導体もしくは それらの塩と反応させて、式 の化合物またはその塩を生成させること〔上記式中、R1、R2、R3、R4、R5 、XおよびYは各々上に定義した通りであり、 Ea は−CO−または−SO2−である〕、または、 2)式 の化合物またはその塩を式 の化合物またはそのカルボキシ基における反応性誘導体もしくはそれらの塩と反 応させて、式 の化合物またはその塩を生成させること〔上記式中、R1、R2、R3、R4、R5 、A、E、XおよびYは各々上に定義した通りである〕、または、 3)式 の化合物またはその塩を脱エステル反応に付して、式 の化合物またはその塩を生成させること〔上記式中、R2、R3、R4、R5、A、 E、XおよびYは各々上に定義した通りであり、 R1 aは、各々に、エステル化されたカルボキシ;エステル化されたカルボキシ もしくはエステル化されたカルボキシ置換アリ−ルで置換された低級アルケニル ;エステル化されたカルボキシ、エステル化されたカルボキシ低級アルカノイル オキシもしくはエステル化されたカルボキシ低級アルコキシイミノで置換された 低級アルキル;エステル化されたカルボキシで置換された低級アルキルチオ;エ ステル化されたカルボキシ置換アリ−ル、エステル化されたカルボキシ置換ピリ ジル、エステル化されたカルボキシ低級アルキルアミノ、N−保護されたエステ ル化されたカルボキシ低級アルキルアミノ、N−エステル化されたカルボキシ低 級アルキル−N−低級アルキルアミノ、エステル化されたカルボキシもしくはエ ステル化されたカルボキシ低級アルコキシイミノで置換されたアルコキシ;もし くはエステル化されたカルボキシで置換された低級アルケニルオキシ;で置換さ れているアリ−ル、ハロアリ−ル、シクロ低級アルキルもしくは複素環基であり ; R1 bは、各々に、カルボキシ;カルボキシで置換された低級アルケニル;カル ボキシもしくはカルボキシ置換アリ−ル、カルボキシ低級アルカノイルオキシも しくはカルボキシ低級アルコキシイミノで置換された低級アルキル;カルボキシ で置換された低級アルキルチオ;カルボキシ置換アリ−ル、カルボキシ置換ピリ ジル、カルボキシ低級アルキルアミノ、N−保護されたカルボキシ低級アルキル アミノ、N−カルボキシ低級アルキル−N−低級アルキルアミノ、カルボキシも しくはカルボキシ低級アルコキシイミノで置換されたアルコキシ;もしくはカル ボキシで置換された低級アルケニルオキシ;で置換されているアリ−ル、ハロア リ−ル、シクロ低級アルキルもしくは複素環基である〕、または、 4)式 の化合物またはその塩を脱エステル反応に付して、式 の化合物またはその塩を生成させること〔上記式中、R1、R2、R3、R5、A、 E、XおよびYは各々上に定義した通りであり、 R4 aは、エステル化されたカルボキシで置換された低級アルコキシ;エステル 化されたカルボキシで置換された低級アルキルチオ;エステル化されたカルボキ シで置換された低級アルキル;または、エステル化されたカルボキシで置換され た低級アルケニルであり; R4 bは、カルボキシで置換された低級アルコキシ;カルボキシで置換された低 級アルキルチオ;カルボキシで置換された低級アルキル;または、カルボキシで 置換された低級アルケニルである〕、または、 5)式 の化合物またはその塩をN−保護基脱離反応に付して、式 の化合物またはその塩を生成させること〔上記式中、R1、R2、R3、R5、A、 E、XおよびYは各々上に定義した通りであり、 R4 cは保護されたアミノ;N−保護されたピペリジルオキシ;N−保護された アミノ低級アルキルアミノ;保護されたアミノで置換された低級アルコキシ;保 護されたアミノで置換された低級アルキルチオ;保護されたアミノで置換された 低級アルキル;保護されたアミノで置換された低級アルキニル;または、N−保 護されたアミノ低級アルキルスルホニルであり; R4 dはアミノ;ピペリジルオキシ;アミノ低級アルキルアミノ;アミノで置換 された低級アルコキシ;アミノで置換された低級アルキルチオ;アミノで置換さ れた低級アルキル;アミノで置換された低級アルキニル;またはアミノ低級アル キルスルホニルである〕、または、 6)式 の化合物またはそのカルボキシ基における反応性誘導体もしくはそれらの塩をア ミンまたはその塩と反応させて、式 の化合物またはその塩を生成させること〔上記式中、R1 b、R2、R3、R4、R5 、A、E、XおよびYは各々上に定義した通りであり、 R1 cは、各々に、置換または無置換N−含有複素環カルボニル;カルバモイル ;置換または無置換低級アルキルカルバモイル;置換または無置換N−含有複素 環カルボニル、カルバモイル、置換または無置換低級アルキルカルバモイルもし くはN−含有複素環カルボニル置換アリ−ルで置換された低級アルケニル;置換 または無置換N−含有複素環カルボニル、カルバモイル、置換または無置換低級 アルキルカルバモイル、置換または無置換N−含有複素環カルボニル低級アルカ ノイルオキシ、カルバモイル低級アルカノイルオキシ、置換または無置換低級ア ルキルカルバモイル低級アルカノイルオキシ、置換または無置換N−含有複素環 カルボニル低級アルコキシイミノ、カルバモイル低級アルコキシイミノもしくは 置換または無置換低級アルキルカルバモイル低級アルコキシイミノで置換された 低級アルキル;置換または無置換N−含有複素環カルボニル、カルバモイルもし くは置換または無置換低級アルキルカルバモイルで置換された低級アルキルチオ ;置換または無置換N−含有複素環カルボニル置換アリ−ル、カルバモイル置換 アリ−ル、置換または無置換低級アルキルカルバモイル置換アリ−ル、置換また は無置換N−含有複素環カルボニル置換ピリジル、カルバモイル置換ピリジル、 置換または無置換低級アルキルカルバモイル置換ピリジル、置換または無置換N −含有複素環カルボニル低級アルキルアミノ、カルバモイル低級アルキルアミノ 、置換または無置換低級アルキルカルバモイル低級アルキルアミノ、N−保護さ れた(置換または無置換N−含有複素環)カルボニル低級アルキルアミノ、N− 保護されたカルバモイル低級アルキルアミノ、N−保護された置換または無置換 低級アルキルカルバモイル低級アルキルアミノ、N−(置換または無置換N−含 有複素環)カルボニル低級アルキル−N−低級アルキルアミノ、N−カルバモイ ル低級アルキル−N−低級アルキルアミノ、置換または無置換N−低級アルキル カルバモイル−N−低級アルキルアミノ、置換または無置換N−含有複素環カル ボニル、カルバモイル、置換または無置換低級アルキルカルバモイル、置換また は無置換N−含有複素環カルボニル低級アルコキシイミノ、カルバモイル低級ア ルコキシイミノもしくは置換または無置換低級アルキルカルバモイル低級アルコ キシイミノで置換されたアルコキシ;もしくは、置換または無置換N−含有複素 環カルボニル、カルバモイルもしくは置換または無置換低級アルキルカルバモイ ルで置換された低級アルケニルオキシ;で置換されているアリ−ル、ハロアリ− ル、シクロ低級アルキルもしくは複素環基である〕、または、 7)式 の化合物またはそのカルボキシ基における反応性誘導体もしくはそれらの塩をア ミンまたはその塩と反応させて、式 の化合物またはその塩を生成させること〔上記式中、R1、R2、R3、R4 b、R5 、A、E、XおよびYは各々上に定義した通りであり、 R4 eは、各々に、置換または無置換N−含有複素環カルボニル、カルバモイル もしくは置換または無置換低級アルキルカルバモイルで置換されている低級アル コキシ、低級アルキルチオ、低級アルキルもしくは低級アルケニルである〕、ま たは、 8)式 の化合物またはその塩を脱ベンジル反応に付して、式 の化合物またはその塩を生成させること〔上記式中、R1、R2、R3、R5、A、 E、XおよびYは各々上に定義した通りであり、 R4 fは、アリ−ルもしくは置換アリ−ルで置換されたメトキシ;または、ア リ−ルもしくは置換アリ−ルで置換されたメトキシで置換されている低級アルキ ルチオであり; R4 gは、ヒドロキシ;またはヒドロキシで置換された低級アルキルチオである 〕、または、 9)式 の化合物またはその塩を式 Z1−R7 (VI) の化合物またはその塩と反応させて、式 の化合物またはその塩を生成させること〔上記式中、R1、R2、R3、R5、A、 E、XおよびYは各々上に定義した通りであり、 R4 gaはヒドロキシであり; R7は、ヒドロキシ、アリ−ル、置換アリ−ル、アシル、アミノ、低級アルキ ルアミノ、アシルアミノ、保護されたアミノもしくは複素環基で置換されていて もよい低級アルキル;またはN−保護されたピペリジルであり; Z1はヒドロキシ;または酸残基であり; R4 hは、ヒドロキシ、アリ−ル、置換アリ−ル、アシル、アミノ、低級アルキ ルアミノ、アシルアミノ、保護されたアミノもしくは複素環基で置換された低級 アルコキシ;またはN−保護されたピペリジルオキシである〕、または、 10)式 の化合物またはその塩をアシル化剤と反応させて、式 の化合物またはその塩を生成させること〔上記式中、R1、R2、R3、R5、A、 E、XおよびYは各々上に定義した通りであり、 R4 daはアミノで置換された低級アルコキシ;アミノで置換された低級アルキ ルチオ;またはアミノで置換された低級アルキルであり; R4 iは、アシルアミノもしくは置換アシルアミノで置換された低級アルコキシ ;アシルアミノもしくは置換アシルアミノで置換された低級アルキルチオ;また はアシルアミノもしくは置換アシルアミノで置換された低級アルキルである〕、 または、 11)式 の化合物またはその塩を、還元剤の存在下に、低級アルカナ−ルまたはN−保護 されたアミノ低級アルカナ−ルと反応させて、式 の化合物またはその塩を生成させること〔上記式中、R1、R2、R3、R5、A、 E、XおよびYは各々上に定義した通りであり、 R4 dbはアミノ;アミノで置換された低級アルコキシ;アミノで置換された低 級アルキルチオ;またはアミノで置換された低級アルキルであり; R4 jは低級アルキルアミノで置換された低級アルコキシ;低級アルキルアミノ で置換された低級アルキルチオ;低級アルキルアミノで置換された低級アルキル ;低級アルキルアミノ;またはN−保護されたアミノ低級アルキルアミノである 〕、または、 12)式 の化合物またはその塩を還元に付して、式 の化合物またはその塩を生成させること〔上記式中、R1、R2、R3、R5、A、 E、XおよびYは各々上に定義した通りである〕、または、 13)式 の化合物またはその塩を脱アシル反応に付して、式 の化合物またはその塩を生成させること〔上記式中、R1、R2、R3、R5、A、 E、XおよびYは各々上に定義した通りであり、 R4 kはアシルオキシである〕、または、 14)式 の化合物またはその塩を式 の化合物またはその塩と反応させて、式 の化合物またはその塩を生成させること〔上記式中、R1、R2、R3、R4、R5 、XおよびYは各々上に定義した通りであり、 Z2は酸残基であり、 Ebは低級アルキレンである〕、または、 15)式 の化合物またはその塩を酸化剤と反応させて、式 の化合物またはその塩を生成させること〔上記式中、R1、R2、R3、R5、Xお よびYは各々上に定義した通りであり、 R4lは、アミノもしくは保護されたアミノで置換された低級アルキルチオで あり; R4 mは、アミノもしくは保護されたアミノで置換された低級アルキルスルフィ ニルまたはアミノもしくは保護されたアミノで置換された低級アルキルスルホニ ルである〕、または、 16)式 の化合物またはその塩を接触還元に付して、式 の化合物またはその塩を生成させること〔上記式中、R1、R2、R3、R4、R5 、A、Eb、XおよびYは各々上に定義した通りであり、 Ecは低級アルケニレンである〕、または、 17)式 の化合物またはその塩を脱ベンジル反応に付して、式 の化合物またはその塩を生成させること〔上記式中、R2、R3、R4、R5、A、 E、XおよびYは各々上に定義した通りであり、 R1 dは、アリ−ルもしくは置換アリ−ルで置換されたメトキシで置換されてい るアリ−ルであり、 R1 eは、ヒドロキシで置換されたアリ−ルである〕、または、 18)式 の化合物またはその塩を式 Z3−R8 (IX) の化合物またはその塩と反応させて、式 の化合物またはその塩を生成させること〔上記式中、R1 e、R2、R3、R4、R5 、A、E、XおよびYは各々上に定義した通りであり、 Z3はヒドロキシまたは酸残基であり、 R8は、アシル、アシルアミノ、保護されたアミノ、アリ−ル、置換アリ−ル 、アシル置換ピリジルもしくはN−保護されたグアニジノで置換されていてもよ い低級アルキルであり; R1 fは、アシル、アシルアミノ、保護されたアミノ、アリ−ル、置換アリ−ル 、アシル置換ピリジルもしくはN−保護されたグアニジノで置換されていてもよ い低級アルコキシで置換されているアリ−ルである〕、または、 19)式 の化合物またはその塩をヒドロキシ保護基脱離反応に付して、式 の化合物またはその塩を生成させること〔上記式中、R1、R2、R4、R5、A、 E、XおよびYは各々上に定義した通りであり、 R3 aはアリ−ルで置換されたメトキシ;アシルオキシ;または置換アシルオキ シである〕、または、 20)式 の化合物またはその塩を式 Z4−R9 (X) の化合物またはその塩と反応させて、式 の化合物またはその塩を生成させること〔上記式中、R1、R2、R4、R5、A、 E、XおよびYは各々上に定義した通りであり、 Z4は酸残基であり、 R9は、エステル化されたカルボキシで置換されていてもよい低級アルキルで あり、 R3 bは、エステル化されたカルボキシで置換されていてもよい低級アルコキシ である〕、または、 21)式 の化合物またはその塩を脱エステル反応に付して、式 の化合物またはその塩を生成させること〔上記式中、R1、R2、R4、R5、A、 E、XおよびYは各々上に定義した通りであり、 R3 cはエステル化されたカルボキシで置換された低級アルコキシであり、 R3 dはカルボキシで置換された低級アルコキシである〕、または、 22)式 の化合物またはその塩を、パラジウム化合物、銅化合物の存在下に、アルキン化 合物と反応させて、式 の化合物またはその塩を生成させること〔上記式中、R1、R2、R3、R5、A、 E、XおよびYは各々上に定義した通りであり、 R4 nはハロゲンであり、 R4 oは、ヒドロキシ、アミノ、保護されたアミノ、低級アルキルスルホニルオ キシもしくはアリ−ルスルホニルオキシで置換されていてもよい低級アルキニル である〕、または、 23)式 の化合物またはその塩を式 Z5−R10 (XI) の化合物と反応させて、式 の化合物またはその塩を生成させること〔上記式中、R1、R2、R3、R5、A、 E、XおよびYは各々上に定義した通りであり、 R4 pは、各々にヒドロキシで置換されている低級アルキルチオ、低級アルキル もしくは低級アルキニルであり、 Z5はハロゲンであり、 R10は低級アルキルスルホニルまたはアリ−ルスルホニルであり、 R4 qは、各々に低級アルキルスルホニルオキシもしくはアリ−ルスルホニルオ キシで置換されている低級アルキルチオ、低級アルキルもしくは低級アルキニル である〕、または、 24)式 の化合物またはその塩をアルカリ金属フタルイミドと反応させて、式 の化合物またはその塩を生成させること〔上記式中、R1、R2、R3、R4 q、R5 、A、E、XおよびYは各々上に定義した通りであり、 R4 rは、各々にフタルイミドで置換された低級アルキルチオ、低級アルキルも しくは低級アルキニルである〕、または、 25)式 の化合物またはその塩を還元剤と反応させて、式 の化合物またはその塩を生成させること〔上記式中、R1、R2、R3、R4 o、R5 、A、E、XおよびYは各々上に定義した通りであり、 R4 sは、ヒドロキシ、アミノ、保護されたアミノ、低級アルキルスルホニルオ キシもしくはアリ−ルスルホニルオキシで置換されていてもよい低級アルキルで ある〕、または、 26)式 の化合物またはその塩を式 の化合物またはその塩と反応させて、式 の化合物またはその塩を生成させること〔上記式中、R1、R2、R3、R4、R5 、XおよびYは各々上に定義した通りであり、 Edは単結合または低級アルキレンである〕、または、 27)式 の化合物またはその塩を、塩基の存在下に、式 Z6−R2 a (XIII) の化合物と反応させて、式 の化合物またはその塩を生成させること〔上記式中、R1、R3、R4、R5、G、 XおよびYは各々上に定義した通りであり、 Z6は酸残基であり、 R2 aは、アリ−ルもしくはアシルで置換されていてもよい低級アルキルである 〕、または、 28)式 の化合物またはその塩をアシル化剤と反応させて、式 の化合物またはその塩を生成させること〔上記式中、R2、R3、R4、R5、A、 E、XおよびYは各々上に定義した通りであり、 R1 gはアミノで置換された低級アルコキシで置換されているアリ−ルであり、 R1 hは、アシルアミノもしくは置換アシルアミノで置換された低級アルコキシ で置換されているアリ−ルである〕、または、 29)式 の化合物またはその塩を還元剤と反応させて、式 の化合物またはその塩を生成させること〔上記式中、R2、R3、R4、R5、A、 E、XおよびYは各々上に定義した通りであり、 R1 iは、オキソピペリジルカルボニルで置換された低級アルコキシで置換され ているアリ−ルであり、 R1 jは、ヒドロキシピペリジルカルボニルで置換された低級アルコキシで置換 されているアリ−ルである〕、または、 30)式 の化合物またはその塩を、還元剤の存在下に、アミン化合物またはその塩と反応 させて、式 の化合物またはその塩を生成させること〔上記式中、R2、R3、R4、R5、A、 E、XおよびYは各々上に定義した通りであり、 R1 kは、ホルミルもしくはオキソピペリジルカルボニルで置換された低級アル コキシで置換されているアリ−ルであり、 R1lは、アミノピペリジルカルボニルもしくはN−低級アルキルピペラジニ ルで置換された低級アルコキシで置換されているアリ−ルである〕、または、 31)式 の化合物またはそのカルボキシ基における反応性誘導体もしくはそれらの塩を低 級アルキルアミノ低級アルカノ−ルと反応させて、式 の化合物またはその塩を生成させること〔上記式中、R2、R3、R4、R5、A、 E、XおよびYは各々上に定義した通りであり、 R1 mは、カルボキシで置換された低級アルコキシで置換されているアリ−ルで あり、 R1 nは、低級アルキルアミノ低級アルコキシカルボニルで置換された低級アル コキシで置換されているアリ−ルである〕、または、 32)式 の化合物またはその塩を還元剤と反応させて、式 の化合物またはその塩を生成させること〔上記式中、R2、R3、R4、R5、A、 E、XおよびYは各々上に定義した通りであり、 R1 oは、エステル化されたカルボキシで置換された低級アルコキシで置換され ているアリ−ルであり、 R1 pは、ヒドロキシで置換された低級アルコキシで置換されているアリ−ルで ある〕、または、 33)式 の化合物またはその塩を酸化反応に付して、式 の化合物またはその塩を生成させること〔上記式中、R1 p、R2、R3、R4、R5 、A、E、XおよびYは各々上に定義した通りであり、 R1 qは、ホルミルで置換された低級アルコキシで置換されているアリ−ルであ る〕、または、 34)式 の化合物またはその塩をアジド化合物と反応させて、式 の化合物またはその塩を生成させること〔上記式中、R2、R3、R4、R5、A、 E、XおよびYは各々上に定義した通りであり、 R1 rは、シアノ置換アリ−ルで置換された低級アルコキシで置換されているア リ−ルであり、 R1 sは、テトラゾリル置換アリ−ルで置換された低級アルコキシで置換されて いるアリ−ルである〕、または、 35)式 の化合物またはその塩をイソ尿素化合物と反応させて、式 の化合物またはその塩を生成させること〔上記式中、R1、R2、R3、R5、A、 E、XおよびYは各々上に定義した通りであり、 R4 tは、アミノで置換された低級アルコキシであり、 R4 uは、グアニジノで置換された低級アルコキシである〕、または、 36)式 の化合物またはその塩をN−保護基脱離反応に付して、式 の化合物またはその塩を生成させること〔上記式中、R2、R3、R4、R5、A、 E、XおよびYは各々上に定義した通りであり、 R1 tは、保護されたアミノ、N−保護されたアミノ低級アルカノイルアミノ、 N−保護されたピペラジニルカルボニルもしくはN−保護されたグアニジノで置 換された低級アルコキシで置換されているアリ−ルであり; R1 uは、アミノ、アミノ低級アルカノイルアミノ、ピペラジニルカルボニルも しくはグアニジノで置換された低級アルコキシで置換されているアリ−ルである 〕、または、 37)式 の化合物またはその塩をN−低級アルキルピペラジン、ジメチルアミノピペリジ ン、アンモニアまたはN,N−ジメチルホルムアミドと反応させて、式 の化合物またはその塩を生成させること〔上記式中、R2、R3、R4、R5、A、 E、XおよびYは各々上に定義した通りであり、 R1 vは、フェノキシカルボニルアミノで置換された低級アルコキシで置換され ているアリ−ルであり、 R1 wは、N−低級アルキルピペラジノカルボニルアミノ、ジメチルアミノピペ リジリルカルボニルアミノ、カルバモイルアミノもしくはジメチルカルバモイル アミノで置換された低級アルコキシで置換されているアリ−ルである〕、または 、 38)式 の化合物またはそのカルボキシ基における反応性誘導体もしくはそれらの塩をヒ ドロキシ化合物またはジアゾ化合物と反応させて、式 の化合物またはその塩を生成させること〔上記式中、R1、R2、R3 c、R3 d、R4 、R5、A、E、XおよびYは各々上に定義した通りである〕、または、 39)式 の化合物またはそのカルボキシ基における反応性誘導体もしくはそれらの塩をア ミンと反応させて、式 の化合物またはその塩を生成させること〔上記式中、R1、R2、R3 d、R4、R5 、A、E、XおよびYは各々上に定義した通りであり、 R3 eは、低級アルキルで置換されていてもよいカルバモイルで置換された低級 アルコキシである〕 を特徴とする前記製造法。
- 【請求項6】有効成分として請求項1の化合物と製薬上許容される実質的に無毒 性の担体または賦形剤とを含有することを特徴とする医薬組成物。
- 【請求項7】医薬として使用するための請求項1の化合物。
- 【請求項8】ヒトまたは動物に請求項1の化合物の有効量を投与することを特徴 とする、高血圧、心不全、腎不全、浮腫、腹水、バソプレッシン分泌異常症候群 、肝硬変、低ナトリウム血症、低カリウム血症、糖尿病、循環障害、脳血管障害 、メニエ−ル症候群または乗物酔いを治療および/または予防する方法。
- 【請求項9】ヒトまたは動物における高血圧、心不全、腎不全、浮腫、腹水、バ ソプレッシン分泌異常症候群、肝硬変、低ナトリウム血症、低カリウム血症、糖 尿病、循環障害、脳血管障害、メニエ−ル症候群または乗物酔いを治療および/ または予防するための医薬品の製造のための請求項1の化合物の使用。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB9511694.3 | 1995-06-09 | ||
GBGB9511694.3A GB9511694D0 (en) | 1995-06-09 | 1995-06-09 | Benzamide derivatives |
PCT/JP1996/001533 WO1996041795A1 (en) | 1995-06-09 | 1996-06-06 | Benzamide derivatives and their use as vasopressin antagonists |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2007259213A Division JP2008074855A (ja) | 1995-06-09 | 2007-09-04 | バソプレッシン拮抗物質としてのベンズアミド誘導体およびその用途 |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH11508244A true JPH11508244A (ja) | 1999-07-21 |
JP4042160B2 JP4042160B2 (ja) | 2008-02-06 |
Family
ID=10775780
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP50289697A Expired - Fee Related JP4042160B2 (ja) | 1995-06-09 | 1996-06-06 | バソプレッシン拮抗物質としてのベンズアミド誘導体およびその用途 |
JP2007259213A Withdrawn JP2008074855A (ja) | 1995-06-09 | 2007-09-04 | バソプレッシン拮抗物質としてのベンズアミド誘導体およびその用途 |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2007259213A Withdrawn JP2008074855A (ja) | 1995-06-09 | 2007-09-04 | バソプレッシン拮抗物質としてのベンズアミド誘導体およびその用途 |
Country Status (22)
Country | Link |
---|---|
US (1) | US6054457A (ja) |
EP (1) | EP0832061B1 (ja) |
JP (2) | JP4042160B2 (ja) |
KR (1) | KR19990022448A (ja) |
CN (1) | CN1192729A (ja) |
AR (1) | AR003005A1 (ja) |
AT (1) | ATE205185T1 (ja) |
AU (1) | AU5911096A (ja) |
CA (1) | CA2223869A1 (ja) |
DE (1) | DE69615025T2 (ja) |
DK (1) | DK0832061T3 (ja) |
EA (1) | EA199800051A1 (ja) |
ES (1) | ES2159738T3 (ja) |
GB (1) | GB9511694D0 (ja) |
GR (1) | GR3036881T3 (ja) |
HU (1) | HUP9802694A3 (ja) |
IL (1) | IL122345A0 (ja) |
MX (1) | MX9709951A (ja) |
PT (1) | PT832061E (ja) |
TR (1) | TR199600488A2 (ja) |
WO (1) | WO1996041795A1 (ja) |
ZA (1) | ZA964895B (ja) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2003503381A (ja) * | 1999-06-25 | 2003-01-28 | ザ インスティテューツ フォア ファーマスーティカル ディスカヴァリー エルエルシー | 置換フェノキシ酢酸 |
JP2006517199A (ja) * | 2003-01-24 | 2006-07-20 | ノバルティス アクチエンゲゼルシャフト | アミド誘導体およびそれらの11−ベータ−ヒドロキシステロイドデヒドロゲナーゼ・タイプ1の阻害剤としての使用 |
JP2008504312A (ja) * | 2004-06-28 | 2008-02-14 | メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフトング | フェニルカルボン酸誘導体および糖尿病の処置のためのその使用 |
JP2008510684A (ja) * | 2004-08-24 | 2008-04-10 | フェリング ベスローテン フェンノートシャップ | バソプレッシンV1a拮抗薬 |
Families Citing this family (62)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9408185D0 (en) * | 1994-04-25 | 1994-06-15 | Fujisawa Pharmaceutical Co | New benzamide derivatives, processes for the preparation thereof and pharmaceutical composition comprising the same |
AUPO395396A0 (en) | 1996-12-02 | 1997-01-02 | Fujisawa Pharmaceutical Co., Ltd. | Benzamide derivatives |
US6022884A (en) | 1997-11-07 | 2000-02-08 | Amgen Inc. | Substituted pyridine compounds and methods of use |
AUPP150098A0 (en) | 1998-01-27 | 1998-02-19 | Fujisawa Pharmaceutical Co., Ltd. | Benzamide derivatives |
US6194458B1 (en) * | 1998-10-30 | 2001-02-27 | Merck & Co., Inc. | Benzamide potassium channel inhibitors |
JP4689042B2 (ja) * | 1998-11-04 | 2011-05-25 | 明治製菓株式会社 | ピコリン酸アミド誘導体、それを有効成分として含有する有害生物防除剤 |
GB9824579D0 (en) | 1998-11-10 | 1999-01-06 | Novartis Ag | Organic compounds |
AU3412800A (en) | 1999-03-25 | 2000-10-16 | Boehringer Ingelheim (Canada) Ltd. | Hsv primase inhibitors |
WO2001017953A1 (en) * | 1999-09-08 | 2001-03-15 | Guilford Pharmaceuticals Inc. | Non-peptidic cyclophilin binding compounds and their use |
PE20020665A1 (es) | 2000-06-15 | 2002-08-14 | Pharmacia Corp | ACIDO CICLOALQUIL FENIL ALCANOICO COMO ANTAGONISTA DE INTEGRINAS OVß3 |
US6531494B1 (en) | 2001-08-29 | 2003-03-11 | Pharmacia Corporation | Gem-substituted αvβ3 antagonists |
US7105682B2 (en) | 2001-01-12 | 2006-09-12 | Amgen Inc. | Substituted amine derivatives and methods of use |
US20030134836A1 (en) | 2001-01-12 | 2003-07-17 | Amgen Inc. | Substituted arylamine derivatives and methods of use |
US7102009B2 (en) | 2001-01-12 | 2006-09-05 | Amgen Inc. | Substituted amine derivatives and methods of use |
US6878714B2 (en) | 2001-01-12 | 2005-04-12 | Amgen Inc. | Substituted alkylamine derivatives and methods of use |
US6995162B2 (en) | 2001-01-12 | 2006-02-07 | Amgen Inc. | Substituted alkylamine derivatives and methods of use |
US6656971B2 (en) | 2001-01-25 | 2003-12-02 | Guilford Pharmaceuticals Inc. | Trisubstituted carbocyclic cyclophilin binding compounds and their use |
US6864255B2 (en) | 2001-04-11 | 2005-03-08 | Amgen Inc. | Substituted triazinyl amide derivatives and methods of use |
SE0102299D0 (sv) | 2001-06-26 | 2001-06-26 | Astrazeneca Ab | Compounds |
SE0102764D0 (sv) | 2001-08-17 | 2001-08-17 | Astrazeneca Ab | Compounds |
US7307088B2 (en) | 2002-07-09 | 2007-12-11 | Amgen Inc. | Substituted anthranilic amide derivatives and methods of use |
EP1542699A4 (en) | 2002-07-15 | 2009-03-25 | Myriad Genetics Inc | COMPOUNDS, COMPOSITIONS AND METHODS OF USE THEREOF |
TWI299664B (en) | 2003-01-06 | 2008-08-11 | Osi Pharm Inc | (2-carboxamido)(3-amino)thiophene compounds |
US7696225B2 (en) | 2003-01-06 | 2010-04-13 | Osi Pharmaceuticals, Inc. | (2-carboxamido)(3-Amino) thiophene compounds |
BRPI0512213A (pt) * | 2004-06-16 | 2008-02-19 | Wyeth Corp | método para tratamento, prevenção ou melhora de uma doença ou distúrbio; composição farmacêutica; processo para a preparação de um composto; e uso de um composto |
AU2005264917A1 (en) | 2004-06-16 | 2006-01-26 | Wyeth | Diphenylimidazopyrimidine and -imidazole amines as inhibitors of B-secretase |
US7507748B2 (en) | 2004-07-22 | 2009-03-24 | Amgen Inc. | Substituted aryl-amine derivatives and methods of use |
AU2006205127A1 (en) * | 2005-01-14 | 2006-07-20 | Wyeth | Amino-imidazolones for the inhibition of beta-secretase |
CA2593857A1 (en) * | 2005-02-01 | 2006-08-10 | Wyeth | Amino-pyridines as inhibitors of .beta.-secretase |
KR20070102751A (ko) * | 2005-02-14 | 2007-10-19 | 와이어쓰 | β-세크레타제 억제제로서의 아졸릴아실구아니딘 |
JP2008534504A (ja) | 2005-03-22 | 2008-08-28 | アゼヴァン ファーマスーティカルズ,インコーポレイテッド | 月経前障害を治療するためのβラクタミルアルカン酸 |
US20060235028A1 (en) * | 2005-04-14 | 2006-10-19 | Li James J | Inhibitors of 11-beta hydroxysteroid dehydrogenase type I |
TW200738683A (en) * | 2005-06-30 | 2007-10-16 | Wyeth Corp | Amino-5-(5-membered)heteroarylimidazolone compounds and the use thereof for β-secretase modulation |
AU2006266167A1 (en) * | 2005-06-30 | 2007-01-11 | Wyeth | Amino-5-(6-membered)heteroarylimidazolone compounds and the use thereof for beta-secretase modulation |
EP1910274B1 (en) | 2005-07-20 | 2012-08-08 | Eli Lilly And Company | Phenyl compounds |
DE602006007012D1 (de) | 2005-07-20 | 2009-07-09 | Lilly Co Eli | Pyridinderivate als dipeptedyl-peptidase-hemmer |
TW200730523A (en) * | 2005-07-29 | 2007-08-16 | Wyeth Corp | Cycloalkyl amino-hydantoin compounds and use thereof for β-secretase modulation |
WO2007038271A1 (en) * | 2005-09-26 | 2007-04-05 | Wyeth | Amino-5- [4- (difluoromethoxy) phenyl] -5-phenylimidazolone compounds as inhibitors of the beta-secretase (bace) |
US8247556B2 (en) | 2005-10-21 | 2012-08-21 | Amgen Inc. | Method for preparing 6-substituted-7-aza-indoles |
AU2006333049A1 (en) * | 2005-12-19 | 2007-07-12 | Wyeth | 2-amino-5-piperidinylimidazolone compounds and use thereof for beta-secretase modulation |
WO2007098086A2 (en) * | 2006-02-17 | 2007-08-30 | Avalon Pharmaceuticals | Hydroxypiperidine derivatives and uses thereof |
WO2007100536A1 (en) * | 2006-02-24 | 2007-09-07 | Wyeth | DIHYDROSPIRO[DIBENZO[A,D][7]ANNULENE-5,4'-IMIDAZOL] COMPOUNDS FOR THE INHIBITION OF β-SECRETASE |
WO2007136790A2 (en) * | 2006-05-18 | 2007-11-29 | Mannkind Corporation | Intracellular kinase inhibitors |
TWI351399B (en) * | 2006-06-12 | 2011-11-01 | Schering Corp | Pharmaceutical formulations and compositions of a |
US20090221703A1 (en) * | 2006-07-09 | 2009-09-03 | Chongxi Yu | High penetration composition and uses thereof |
US20090238763A1 (en) | 2006-07-09 | 2009-09-24 | Chongxi Yu | High penetration compositions and uses thereof |
US7700606B2 (en) * | 2006-08-17 | 2010-04-20 | Wyeth Llc | Imidazole amines as inhibitors of β-secretase |
EP2064201A2 (en) * | 2006-09-21 | 2009-06-03 | Wyeth | Indolylalkylpyridin-2-amines for the inhibition of beta-secretase |
PE20090160A1 (es) * | 2007-03-20 | 2009-02-11 | Wyeth Corp | COMPUESTOS AMINO-5-[4-(DIFLUOROMETOXI)FENIL SUSTITUIDO]-5-FENILIMIDAZOLONA COMO INHIBIDORES DE ß-SECRETASA |
CL2008000791A1 (es) * | 2007-03-23 | 2008-05-30 | Wyeth Corp | Compuestos derivados de 2-amino-5-(4-difluorometoxi-fenil)-5-fenil-imidazolidin-4-ona; composicion farmaceutica que comprende a dichos compuestos; y su uso en el tratamiento de una enfermedad asociada con la actividad bace excesiva, tales como enferm |
PL2170826T3 (pl) * | 2007-06-04 | 2022-09-05 | Techfields Inc | Proleki nsaia o bardzo wysokim współczynniku przenikania przez skórę i błony oraz ich nowe zastosowania lecznicze |
CA3213470A1 (en) | 2008-12-04 | 2010-06-10 | Chongxi Yu | High penetration compositions and their applications |
US9376424B2 (en) | 2010-07-01 | 2016-06-28 | Azevan Pharmaceuticals, Inc. | Methods for treating post traumatic stress disorder |
TW201329025A (zh) | 2011-11-01 | 2013-07-16 | Astex Therapeutics Ltd | 醫藥化合物 |
MX2015011445A (es) | 2013-03-15 | 2016-04-20 | Global Blood Therapeutics Inc | Compuestos y usos de estos para la modulacion de la hemoglobina. |
WO2014165827A1 (en) | 2013-04-05 | 2014-10-09 | Salk Institute For Biological Studies | Ppar agonists |
EA201992707A1 (ru) | 2013-11-18 | 2020-06-30 | Глобал Блад Терапьютикс, Инк. | Соединения и их применения для модуляции гемоглобина |
JP7255967B2 (ja) | 2014-03-28 | 2023-04-11 | アゼヴァン ファーマスーティカルズ,インコーポレイテッド | 神経変性疾患を治療するための組成物および方法 |
WO2016057322A1 (en) | 2014-10-08 | 2016-04-14 | Salk Institute For Biological Studies | Ppar agonists and methods of use thereof |
PT3359528T (pt) | 2015-10-07 | 2022-04-07 | Salk Inst Biological Studies | Agonistas de ppar, compostos, composições farmacêuticas e métodos de utilização dos mesmos |
KR102430906B1 (ko) | 2016-04-13 | 2022-08-10 | 미토브리지, 인크. | Ppar 효능제, 화합물, 제약 조성물, 및 그의 사용 방법 |
BR112020005107A2 (pt) | 2017-09-15 | 2020-11-03 | Azevan Pharmaceuticals, Inc. | composições e métodos para o tratamento de lesão cerebral |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2802029A (en) * | 1951-10-17 | 1957-08-06 | Knoll Ag | Bromsalicyloyl-chloranilide |
US2995488A (en) * | 1955-03-24 | 1961-08-08 | Fmc Corp | Synergistic insecticidal compositions |
US4146386A (en) * | 1975-02-03 | 1979-03-27 | Monsanto Company | Phthalic dianilides and their use as plant growth regulators |
SU1156362A1 (ru) * | 1983-02-17 | 1991-07-30 | Пермский государственный фармацевтический институт | Ариламиды П-(2 @ ,4 @ )- или (3 @ ,4 @ )-диметоксибензилантраниловых кислот как промежуточные вещества дл синтеза биологически активных перхлоратов 1-[(2 @ ,4 @ ) или (3 @ ,4 @ )-диметоксибензил]-2-метил-3-арил-4-(3Н)-хиназолинони |
JPS608247A (ja) * | 1983-06-28 | 1985-01-17 | Showa Denko Kk | フタラミド誘導体及び農園芸用殺菌剤 |
US4510139A (en) * | 1984-01-06 | 1985-04-09 | Sterling Drug Inc. | Substituted aminobenzamides and their use as agents which inhibit lipoxygenase activity |
DE3419009A1 (de) * | 1984-05-22 | 1985-11-28 | Dr. Karl Thomae Gmbh, 7950 Biberach | Neue substituierte bis(4-aminophenyl)sulfone, ihre herstellung und ihre verwendung als arzneimittel |
US4764619A (en) * | 1985-03-26 | 1988-08-16 | Asahi Glass Company Ltd. | Optically active compounds, smectic liquid crystal compositions containing them and smectic liquid crystal display devices |
DE3523705A1 (de) * | 1985-07-03 | 1987-01-08 | Hoechst Ag | Arzneimittel und deren verwendung |
SU1754712A1 (ru) * | 1989-12-21 | 1992-08-15 | Институт медицинской паразитологии и тропической медицины им.Е.И.Марциновского | N-(3-нитро-4-хлорфенилсульфонил)-антранилова кислота в качестве промежуточного продукта дл получени N-(4-хлорфенил)-2-[(3-нитро-4-хлорфенилсульфонил)-амино]-5-бромбензамида, обладающего противотрихоцефалезной активностью |
GB9307527D0 (en) * | 1993-04-13 | 1993-06-02 | Fujisawa Pharmaceutical Co | New venzamide derivatives,processes for the preparation thereof and pharmaceutical composition comprising the same |
GB9408185D0 (en) * | 1994-04-25 | 1994-06-15 | Fujisawa Pharmaceutical Co | New benzamide derivatives, processes for the preparation thereof and pharmaceutical composition comprising the same |
JP3582199B2 (ja) * | 1995-01-31 | 2004-10-27 | 三菱化学株式会社 | 静電荷像現像用帯電制御剤及びそれを用いたトナー |
AU4715996A (en) * | 1995-02-13 | 1996-09-04 | Bayer Aktiengesellschaft | Substituted heterocyclic compounds and their use as fungicides |
JP3162953B2 (ja) * | 1995-06-07 | 2001-05-08 | 株式会社資生堂 | ピラゾリジン誘導体及びラジカルスカベンジャー、虚血再潅流障害抑制剤 |
-
1995
- 1995-06-09 GB GBGB9511694.3A patent/GB9511694D0/en active Pending
-
1996
- 1996-06-06 KR KR1019970708929A patent/KR19990022448A/ko not_active Application Discontinuation
- 1996-06-06 WO PCT/JP1996/001533 patent/WO1996041795A1/en not_active Application Discontinuation
- 1996-06-06 DK DK96916324T patent/DK0832061T3/da active
- 1996-06-06 EP EP96916324A patent/EP0832061B1/en not_active Expired - Lifetime
- 1996-06-06 DE DE69615025T patent/DE69615025T2/de not_active Expired - Lifetime
- 1996-06-06 IL IL12234596A patent/IL122345A0/xx unknown
- 1996-06-06 AT AT96916324T patent/ATE205185T1/de not_active IP Right Cessation
- 1996-06-06 PT PT96916324T patent/PT832061E/pt unknown
- 1996-06-06 HU HU9802694A patent/HUP9802694A3/hu unknown
- 1996-06-06 EA EA199800051A patent/EA199800051A1/ru unknown
- 1996-06-06 CN CN96196175A patent/CN1192729A/zh active Pending
- 1996-06-06 ES ES96916324T patent/ES2159738T3/es not_active Expired - Lifetime
- 1996-06-06 MX MX9709951A patent/MX9709951A/es unknown
- 1996-06-06 CA CA002223869A patent/CA2223869A1/en not_active Abandoned
- 1996-06-06 AU AU59110/96A patent/AU5911096A/en not_active Abandoned
- 1996-06-06 US US08/973,103 patent/US6054457A/en not_active Expired - Fee Related
- 1996-06-06 JP JP50289697A patent/JP4042160B2/ja not_active Expired - Fee Related
- 1996-06-07 ZA ZA964895A patent/ZA964895B/xx unknown
- 1996-06-07 TR TR96/00488A patent/TR199600488A2/xx unknown
- 1996-11-06 AR ARP960103098A patent/AR003005A1/es unknown
-
2001
- 2001-10-11 GR GR20010401746T patent/GR3036881T3/el unknown
-
2007
- 2007-09-04 JP JP2007259213A patent/JP2008074855A/ja not_active Withdrawn
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2003503381A (ja) * | 1999-06-25 | 2003-01-28 | ザ インスティテューツ フォア ファーマスーティカル ディスカヴァリー エルエルシー | 置換フェノキシ酢酸 |
JP2006517199A (ja) * | 2003-01-24 | 2006-07-20 | ノバルティス アクチエンゲゼルシャフト | アミド誘導体およびそれらの11−ベータ−ヒドロキシステロイドデヒドロゲナーゼ・タイプ1の阻害剤としての使用 |
JP2008504312A (ja) * | 2004-06-28 | 2008-02-14 | メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフトング | フェニルカルボン酸誘導体および糖尿病の処置のためのその使用 |
JP2008510684A (ja) * | 2004-08-24 | 2008-04-10 | フェリング ベスローテン フェンノートシャップ | バソプレッシンV1a拮抗薬 |
JP2010285442A (ja) * | 2004-08-24 | 2010-12-24 | Vantia Ltd | バソプレッシンV1a拮抗薬 |
US8202858B2 (en) | 2004-08-24 | 2012-06-19 | Vantia Limited | Vasopressin V1a antagonists |
Also Published As
Publication number | Publication date |
---|---|
DE69615025D1 (de) | 2001-10-11 |
JP2008074855A (ja) | 2008-04-03 |
EA199800051A1 (ru) | 1998-08-27 |
ATE205185T1 (de) | 2001-09-15 |
AU5911096A (en) | 1997-01-09 |
WO1996041795A1 (en) | 1996-12-27 |
IL122345A0 (en) | 1998-04-05 |
JP4042160B2 (ja) | 2008-02-06 |
DE69615025T2 (de) | 2002-03-21 |
EP0832061A1 (en) | 1998-04-01 |
US6054457A (en) | 2000-04-25 |
EP0832061B1 (en) | 2001-09-05 |
TR199600488A2 (tr) | 1997-05-21 |
AR003005A1 (es) | 1998-05-27 |
HUP9802694A3 (en) | 1999-03-29 |
ZA964895B (en) | 1996-12-12 |
PT832061E (pt) | 2002-02-28 |
GR3036881T3 (en) | 2002-01-31 |
CN1192729A (zh) | 1998-09-09 |
ES2159738T3 (es) | 2001-10-16 |
CA2223869A1 (en) | 1996-12-27 |
HUP9802694A1 (hu) | 1999-02-01 |
DK0832061T3 (da) | 2001-11-19 |
MX9709951A (es) | 1998-03-29 |
GB9511694D0 (en) | 1995-08-02 |
KR19990022448A (ko) | 1999-03-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP4042160B2 (ja) | バソプレッシン拮抗物質としてのベンズアミド誘導体およびその用途 | |
JP4625969B2 (ja) | ベンズアミド誘導体 | |
JP3845869B2 (ja) | バソプレッシン拮抗物質としてのベンズアミド誘導体 | |
RU2012556C1 (ru) | Способ получения производных циклоалкилглутарамида или их фармацевтически приемлемых солей | |
JP3342485B2 (ja) | 芳香族スルホンアミド系ヒドロキサム酸誘導体 | |
JP2008524154A (ja) | Ccケモカイン受容体ccr1のアンタゴニストとしてのピペリジン誘導体類及び抗−炎症剤としてのそれらの使用 | |
JPH11501289A (ja) | No介在疾患の予防および/または治療のためのペプチド化合物 | |
JPH11505502A (ja) | マトリックスメタロプロテイナーゼ阻害剤としてのアリールスルホンアミド置換ヒドロキサム酸類 | |
KR102524421B1 (ko) | 벤젠 축합 헤테로환 유도체 및 이를 포함하는 약학 조성물 | |
RU2161155C2 (ru) | Производные n-(3-пиперидинилкарбонил)-бета-аланина в качестве антагонистов фактора активации тромбоцитов (фат), способ получения, фармацевтическая композиция и способ лечения | |
JP2002533434A (ja) | 細胞接着阻害抗炎症および免疫抑制化合物 | |
KR100793095B1 (ko) | Bace 저해효능을 가진 신규한 술폰 아미드 유도체 | |
JP3353301B2 (ja) | Pla▲下2▼阻害剤としてのエステル類およびアミド類 | |
JP2002542228A (ja) | Mmp阻害剤 | |
JP3943332B2 (ja) | トリペプチジルペプチダーゼインヒビター | |
CA3126495A1 (en) | Carbamate derivatives and uses thereof | |
JP2002047272A (ja) | ポリアミンアミド誘導体 | |
JP2002518470A (ja) | ヒトcd23の産生およびその放出の阻害剤としてのヒドロキサム酸誘導体 | |
JP2008505929A (ja) | オキシム誘導体ヒドロキシエチルアミン系のアスパラギン酸プロテアーゼ阻害薬 | |
JP2998698B2 (ja) | β−アラニン誘導体およびその製造法 | |
JPH07138221A (ja) | アミジノ化合物 | |
MXPA99005822A (en) | Piperazine compounds as inhibitors of mmp or tnf | |
JP2000001486A (ja) | グアニジン誘導体 | |
JPH1081671A (ja) | 新規ペプチド化合物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RD01 | Notification of change of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7426 Effective date: 20050223 |
|
A711 | Notification of change in applicant |
Free format text: JAPANESE INTERMEDIATE CODE: A712 Effective date: 20050520 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20070710 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20070904 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20071023 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20071105 |
|
R150 | Certificate of patent or registration of utility model |
Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20101122 Year of fee payment: 3 |
|
LAPS | Cancellation because of no payment of annual fees |